Serotonin	HMDB_SMPDB	Samples:	2	Pathways:	3	Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin 	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin 
Calcium	HMDB_SMPDB	Samples:	3	Pathways:	5	Phosphatidylinositol Phosphate Metabolism	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	Joubert syndrome	Etoposide Metabolism Pathway	Fc Epsilon Receptor I Signaling in Mast Cells
Adenosine triphosphate	HMDB_SMPDB	Samples:	5	Pathways:	102	Isovaleric acidemia	Zoledronate Pathway	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	Fluvastatin Pathway	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Pentose Phosphate Pathway	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E3)	Smith-Lemli-Opitz Syndrome (SLOS)	Valine, Leucine and Isoleucine Degradation	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Maple Syrup Urine Disease	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Beta-Ketothiolase Deficiency	Glucose-6-phosphate dehydrogenase deficiency	Triosephosphate isomerase	Mevalonic aciduria	Etoposide Metabolism Pathway	Ribose-5-phosphate isomerase deficiency	Rosuvastatin Pathway	Adefovir Dipivoxil Metabolism Pathway	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	Ibandronate Pathway	Carnitine palmitoyl transferase deficiency (I)	Desmosterolosis	Atorvastatin Pathway	Phosphatidylinositol Phosphate Metabolism	3-Methylglutaconic Aciduria Type I	Isobutyryl-coa dehydrogenase deficiency	Joubert syndrome	3-Methylglutaconic Aciduria Type III	Warburg Effect	The oncogenic action of Fumarate	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	Lovastatin Pathway	Fatty acid Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Gluconeogenesis	Fructosuria	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Isovaleric Aciduria	Cholesteryl ester storage disease	Steroid Biosynthesis	Glycogenosis, Type IC	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Risedronate Pathway	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Congenital lactic acidosis	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin 	Hyper-IgD syndrome	Fructose intolerance, hereditary	Simvastatin Action Pathway	Corticotropin Activation of Cortisol Production	Cerivastatin Pathway	Glutaminolysis and Cancer	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Pravastatin Pathway	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	CHILD Syndrome	Methylmalonic Aciduria	Pamidronate Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Doxorubicin Metabolism Pathway	Tenofovir Metabolism Pathway	Glycogenosis, Type IB	Hypercholesterolemia	Fructose-1,6-diphosphatase deficiency	Alendronate pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	Intracellular Signalling Through Histamine H2 Receptor and Histamine	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Transaldolase deficiency	Fanconi-bickel syndrome	Mitochondrial complex II deficiency	Wolman disease	Ethylmalonic Encephalopathy	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	Spermidine and Spermine Biosynthesis	Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Mitochondrial Electron Transport Chain	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glycolysis	3-hydroxyisobutyric aciduria
Potassium	HMDB_SMPDB	Samples:	5	Pathways:	5	Fanconi-bickel syndrome	Glycolysis	Spermidine and Spermine Biosynthesis	Warburg Effect	Glycogenosis, Type VII. Tarui disease
ADP	HMDB_SMPDB	Samples:	5	Pathways:	94	Isovaleric acidemia	Zoledronate Pathway	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	Fluvastatin Pathway	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Pentose Phosphate Pathway	Lovastatin Action Pathway	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E3)	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Valine, Leucine and Isoleucine Degradation	Maple Syrup Urine Disease	Rosuvastatin Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Beta-Ketothiolase Deficiency	Glucose-6-phosphate dehydrogenase deficiency	Triosephosphate isomerase	Mevalonic aciduria	Etoposide Metabolism Pathway	Zoledronate Action Pathway	Ribose-5-phosphate isomerase deficiency	Rosuvastatin Pathway	Adefovir Dipivoxil Metabolism Pathway	Ibandronate Pathway	Desmosterolosis	Risedronate Action Pathway	Atorvastatin Pathway	Phosphatidylinositol Phosphate Metabolism	3-Methylglutaconic Aciduria Type I	Alendronate Action Pathway	Isobutyryl-coa dehydrogenase deficiency	Joubert syndrome	3-Methylglutaconic Aciduria Type III	Warburg Effect	Mercaptopurine Action Pathway	Fluvastatin Action Pathway	The oncogenic action of Fumarate	Lovastatin Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Gluconeogenesis	Fructosuria	Isovaleric Aciduria	Cholesteryl ester storage disease	Steroid Biosynthesis	Glycogenosis, Type IC	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Risedronate Pathway	Congenital lactic acidosis	Hyper-IgD syndrome	Fructose intolerance, hereditary	Simvastatin Action Pathway	Cerivastatin Pathway	Glutaminolysis and Cancer	Pravastatin Pathway	Pravastatin Action Pathway	CHILD Syndrome	Methylmalonic Aciduria	Azathioprine Action Pathway	Pamidronate Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Atorvastatin Action Pathway	Doxorubicin Metabolism Pathway	Tenofovir Metabolism Pathway	Glycogenosis, Type IB	Hypercholesterolemia	Cerivastatin Action Pathway	Fructose-1,6-diphosphatase deficiency	Alendronate pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Thioguanine Action Pathway	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ibandronate Action Pathway	Etoposide Action Pathway	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Transaldolase deficiency	Fanconi-bickel syndrome	Mitochondrial complex II deficiency	Wolman disease	Fumarase deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Mitochondrial Electron Transport Chain	Glycolysis	3-hydroxyisobutyric aciduria
Phosphate	HMDB_SMPDB	Samples:	5	Pathways:	87	Isovaleric acidemia	Zoledronate Pathway	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	Fluvastatin Pathway	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Pentose Phosphate Pathway	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E3)	Smith-Lemli-Opitz Syndrome (SLOS)	Valine, Leucine and Isoleucine Degradation	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Maple Syrup Urine Disease	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Beta-Ketothiolase Deficiency	Glucose-6-phosphate dehydrogenase deficiency	Triosephosphate isomerase	Mevalonic aciduria	Etoposide Metabolism Pathway	Ribose-5-phosphate isomerase deficiency	Rosuvastatin Pathway	Insulin Signalling	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Phosphatidylinositol Phosphate Metabolism	3-Methylglutaconic Aciduria Type I	Isobutyryl-coa dehydrogenase deficiency	Joubert syndrome	3-Methylglutaconic Aciduria Type III	Warburg Effect	The oncogenic action of Fumarate	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	Lovastatin Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Gluconeogenesis	Fructosuria	Isovaleric Aciduria	Cholesteryl ester storage disease	Steroid Biosynthesis	Glycogenosis, Type IC	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Risedronate Pathway	Congenital lactic acidosis	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin 	Hyper-IgD syndrome	Fructose intolerance, hereditary	Simvastatin Action Pathway	Cerivastatin Pathway	Glutaminolysis and Cancer	Pravastatin Pathway	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	CHILD Syndrome	Methylmalonic Aciduria	Pamidronate Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Doxorubicin Metabolism Pathway	Glycogenosis, Type IB	Hypercholesterolemia	Fructose-1,6-diphosphatase deficiency	Alendronate pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	Intracellular Signalling Through Histamine H2 Receptor and Histamine	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Transaldolase deficiency	Fanconi-bickel syndrome	Mitochondrial complex II deficiency	Wolman disease	Fumarase deficiency	Spermidine and Spermine Biosynthesis	Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Mitochondrial Electron Transport Chain	Glycolysis	3-hydroxyisobutyric aciduria
Water	HMDB_SMPDB	Samples:	5	Pathways:	94	Isovaleric acidemia	Zoledronate Pathway	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	Fluvastatin Pathway	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Pentose Phosphate Pathway	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E3)	Smith-Lemli-Opitz Syndrome (SLOS)	Valine, Leucine and Isoleucine Degradation	Maple Syrup Urine Disease	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Beta-Ketothiolase Deficiency	Glucose-6-phosphate dehydrogenase deficiency	Triosephosphate isomerase	Mevalonic aciduria	Fatty Acid Elongation In Mitochondria	Etoposide Metabolism Pathway	Ribose-5-phosphate isomerase deficiency	Rosuvastatin Pathway	Ibandronate Pathway	Carnitine palmitoyl transferase deficiency (I)	Desmosterolosis	Atorvastatin Pathway	Phosphatidylinositol Phosphate Metabolism	3-Methylglutaconic Aciduria Type I	Isobutyryl-coa dehydrogenase deficiency	Joubert syndrome	3-Methylglutaconic Aciduria Type III	Warburg Effect	The oncogenic action of Fumarate	Lovastatin Pathway	Fatty acid Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Gluconeogenesis	Fructosuria	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Isovaleric Aciduria	Cholesteryl ester storage disease	Steroid Biosynthesis	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Glycogenosis, Type IC	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Risedronate Pathway	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Congenital lactic acidosis	Hyper-IgD syndrome	Fructose intolerance, hereditary	Simvastatin Action Pathway	Cerivastatin Pathway	Glutaminolysis and Cancer	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Degradation of Superoxides	Pravastatin Pathway	CHILD Syndrome	Methylmalonic Aciduria	Pamidronate Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Doxorubicin Metabolism Pathway	Glycogenosis, Type IB	Hypercholesterolemia	Fructose-1,6-diphosphatase deficiency	Alendronate pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Transaldolase deficiency	Fanconi-bickel syndrome	Mitochondrial complex II deficiency	Wolman disease	Ethylmalonic Encephalopathy	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	Spermidine and Spermine Biosynthesis	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Mitochondrial Electron Transport Chain	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glycolysis	3-hydroxyisobutyric aciduria
Alpha-ketoisovaleric acid	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
(S)-3-Hydroxyisobutyric acid	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Biotin	HMDB_SMPDB	Samples:	5	Pathways:	39	Isovaleric acidemia	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Congenital lactic acidosis	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	3-hydroxyisobutyric aciduria	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Valine, Leucine and Isoleucine Degradation	Maple Syrup Urine Disease	Methylmalonic Aciduria	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Pyruvate dehydrogenase deficiency (E2)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Mitochondrial complex II deficiency	Isobutyryl-coa dehydrogenase deficiency	Fumarase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Gluconeogenesis	Isovaleric Aciduria
Acetoacetic acid	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
L-Glutamic acid	HMDB_SMPDB	Samples:	5	Pathways:	23	Isovaleric acidemia	Glutaric Aciduria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	3-Methylglutaconic Aciduria Type IV	The oncogenic action of 2-hydroxyglutarate	Glutaminolysis and Cancer	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Isovaleric Aciduria	Valine, Leucine and Isoleucine Degradation	3-Methylglutaconic Aciduria Type I	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	Maple Syrup Urine Disease	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
L-Isoleucine	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Methylmalonic acid	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Oxoglutaric acid	HMDB_SMPDB	Samples:	5	Pathways:	40	Isovaleric acidemia	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glutaric Aciduria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Congenital lactic acidosis	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	3-hydroxyisobutyric aciduria	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Valine, Leucine and Isoleucine Degradation	Maple Syrup Urine Disease	Methylmalonic Aciduria	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Pyruvate dehydrogenase deficiency (E2)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Mitochondrial complex II deficiency	Isobutyryl-coa dehydrogenase deficiency	Fumarase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Gluconeogenesis	Isovaleric Aciduria
Succinic acid	HMDB_SMPDB	Samples:	5	Pathways:	32	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Congenital lactic acidosis	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	3-hydroxyisobutyric aciduria	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Valine, Leucine and Isoleucine Degradation	Maple Syrup Urine Disease	Methylmalonic Aciduria	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Pyruvate dehydrogenase deficiency (E2)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Mitochondrial complex II deficiency	Isobutyryl-coa dehydrogenase deficiency	Fumarase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Mitochondrial Electron Transport Chain	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Isovaleric Aciduria
3-Methyl-2-oxovaleric acid	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Hydrogen carbonate	HMDB_SMPDB	Samples:	5	Pathways:	39	Isovaleric acidemia	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Congenital lactic acidosis	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	3-hydroxyisobutyric aciduria	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Valine, Leucine and Isoleucine Degradation	Maple Syrup Urine Disease	Methylmalonic Aciduria	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Pyruvate dehydrogenase deficiency (E2)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Mitochondrial complex II deficiency	Isobutyryl-coa dehydrogenase deficiency	Fumarase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Gluconeogenesis	Isovaleric Aciduria
L-Leucine	HMDB_SMPDB	Samples:	5	Pathways:	18	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Ketoleucine	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
L-Valine	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
NAD	HMDB_SMPDB	Samples:	5	Pathways:	63	Isovaleric acidemia	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Fructosuria	Glutaric Aciduria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Propionic Acidemia	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Congenital lactic acidosis	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Fructose intolerance, hereditary	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	3-hydroxyisobutyric aciduria	Fructose and Mannose Degradation	Isovaleric Aciduria	Glutaminolysis and Cancer	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Valine, Leucine and Isoleucine Degradation	Maple Syrup Urine Disease	Methylmalonic Aciduria	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Beta-Ketothiolase Deficiency	Fatty acid Metabolism	Doxorubicin Metabolism Pathway	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Fatty Acid Elongation In Mitochondria	Etoposide Metabolism Pathway	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Carnitine palmitoyl transferase deficiency (I)	3-Methylglutaconic Aciduria Type I	Fanconi-bickel syndrome	Mitochondrial complex II deficiency	Ethylmalonic Encephalopathy	Isobutyryl-coa dehydrogenase deficiency	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Mitochondrial Electron Transport Chain	Glycolysis	Trifunctional protein deficiency	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Gluconeogenesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)
Lipoamide	HMDB_SMPDB	Samples:	5	Pathways:	32	Isovaleric acidemia	Glutaric Aciduria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Congenital lactic acidosis	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	3-hydroxyisobutyric aciduria	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Valine, Leucine and Isoleucine Degradation	Maple Syrup Urine Disease	Methylmalonic Aciduria	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Pyruvate dehydrogenase deficiency (E2)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Mitochondrial complex II deficiency	Isobutyryl-coa dehydrogenase deficiency	Fumarase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Isovaleric Aciduria
Dihydrolipoamide	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Methacrylyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Succinyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	31	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Congenital lactic acidosis	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	Glutaminolysis and Cancer	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Isovaleric Aciduria	Pyruvate dehydrogenase deficiency (E3)	Valine, Leucine and Isoleucine Degradation	3-Methylglutaconic Aciduria Type I	Mitochondrial complex II deficiency	Isobutyryl-coa dehydrogenase deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Fumarase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	Maple Syrup Urine Disease	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
2-Methylbutyryl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
(S)-3-Hydroxyisobutyryl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
3-Methylglutaconyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Isovaleryl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
2-Methylacetoacetyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Acetyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	80	Isovaleric acidemia	Zoledronate Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	Fluvastatin Pathway	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Lovastatin Action Pathway	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E3)	Smith-Lemli-Opitz Syndrome (SLOS)	Valine, Leucine and Isoleucine Degradation	Pamidronate Action Pathway	Maple Syrup Urine Disease	Rosuvastatin Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Beta-Ketothiolase Deficiency	Mevalonic aciduria	Fatty Acid Elongation In Mitochondria	Zoledronate Action Pathway	Rosuvastatin Pathway	Ibandronate Pathway	Carnitine palmitoyl transferase deficiency (I)	Risedronate Action Pathway	Desmosterolosis	3-Methylglutaconic Aciduria Type I	Atorvastatin Pathway	Alendronate Action Pathway	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	Fluvastatin Action Pathway	The oncogenic action of Fumarate	Lovastatin Pathway	Fatty acid Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Isovaleric Aciduria	Cholesteryl ester storage disease	Steroid Biosynthesis	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Risedronate Pathway	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Congenital lactic acidosis	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Glutaminolysis and Cancer	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Pravastatin Pathway	Pravastatin Action Pathway	CHILD Syndrome	Methylmalonic Aciduria	Pamidronate Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Atorvastatin Action Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Alendronate pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Ibandronate Action Pathway	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Mitochondrial complex II deficiency	Ethylmalonic Encephalopathy	Wolman disease	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	3-hydroxyisobutyric aciduria
Isobutyryl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
FAD	HMDB_SMPDB	Samples:	5	Pathways:	83	Isovaleric acidemia	Zoledronate Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	Fluvastatin Pathway	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Lovastatin Action Pathway	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E3)	Smith-Lemli-Opitz Syndrome (SLOS)	Valine, Leucine and Isoleucine Degradation	Pamidronate Action Pathway	Maple Syrup Urine Disease	Rosuvastatin Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Beta-Ketothiolase Deficiency	Mevalonic aciduria	Zoledronate Action Pathway	Rosuvastatin Pathway	Ibandronate Pathway	Carnitine palmitoyl transferase deficiency (I)	Risedronate Action Pathway	Desmosterolosis	3-Methylglutaconic Aciduria Type I	Atorvastatin Pathway	Alendronate Action Pathway	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	Mercaptopurine Action Pathway	Fluvastatin Action Pathway	The oncogenic action of Fumarate	Lovastatin Pathway	Fatty acid Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Isovaleric Aciduria	Cholesteryl ester storage disease	Steroid Biosynthesis	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Risedronate Pathway	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Congenital lactic acidosis	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Glutaminolysis and Cancer	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Pravastatin Pathway	Pravastatin Action Pathway	CHILD Syndrome	Methylmalonic Aciduria	Pamidronate Pathway	Azathioprine Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Atorvastatin Action Pathway	Doxorubicin Metabolism Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Alendronate pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Thioguanine Action Pathway	Ibandronate Action Pathway	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Mitochondrial complex II deficiency	Ethylmalonic Encephalopathy	Wolman disease	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Mitochondrial Electron Transport Chain	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	3-hydroxyisobutyric aciduria
Propionyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
2-Methyl-3-hydroxybutyryl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Thiamine pyrophosphate	HMDB_SMPDB	Samples:	5	Pathways:	32	Isovaleric acidemia	Glutaric Aciduria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Congenital lactic acidosis	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	3-hydroxyisobutyric aciduria	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Valine, Leucine and Isoleucine Degradation	Maple Syrup Urine Disease	Methylmalonic Aciduria	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Pyruvate dehydrogenase deficiency (E2)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Mitochondrial complex II deficiency	Isobutyryl-coa dehydrogenase deficiency	Fumarase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Isovaleric Aciduria
3-Hydroxy-3-methylglutaryl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	40	Isovaleric acidemia	Steroid Biosynthesis	Cholesteryl ester storage disease	Zoledronate Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Hyper-IgD syndrome	3-Methylglutaconic Aciduria Type IV	Simvastatin Action Pathway	Cerivastatin Pathway	3-hydroxyisobutyric aciduria	Smith-Lemli-Opitz Syndrome (SLOS)	Valine, Leucine and Isoleucine Degradation	Lovastatin Pathway	Pravastatin Pathway	Maple Syrup Urine Disease	CHILD Syndrome	Methylmalonic Aciduria	Pamidronate Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	Mevalonic aciduria	Hypercholesterolemia	Alendronate pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Ibandronate Pathway	Desmosterolosis	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Atorvastatin Pathway	3-Methylglutaconic Aciduria Type I	Wolman disease	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Isovaleric Aciduria
Oxygen	HMDB_SMPDB	Samples:	5	Pathways:	62	Isovaleric acidemia	Steroid Biosynthesis	Cholesteryl ester storage disease	Zoledronate Pathway	Glutaric Aciduria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	The oncogenic action of Succinate	Risedronate Pathway	Fluvastatin Pathway	Propionic Acidemia	Hyper-IgD syndrome	Lovastatin Action Pathway	3-Methylglutaconic Aciduria Type IV	Simvastatin Action Pathway	Cerivastatin Pathway	3-hydroxyisobutyric aciduria	Glutaminolysis and Cancer	Smith-Lemli-Opitz Syndrome (SLOS)	Valine, Leucine and Isoleucine Degradation	Pamidronate Action Pathway	Degradation of Superoxides	Lovastatin Pathway	Pravastatin Pathway	Pravastatin Action Pathway	Maple Syrup Urine Disease	CHILD Syndrome	Methylmalonic Aciduria	Pamidronate Pathway	Rosuvastatin Action Pathway	Azathioprine Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Atorvastatin Action Pathway	Beta-Ketothiolase Deficiency	Mevalonic aciduria	Hypercholesterolemia	Cerivastatin Action Pathway	Alendronate pathway	Etoposide Metabolism Pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Thioguanine Action Pathway	Rosuvastatin Pathway	Ibandronate Action Pathway	Etoposide Action Pathway	Ibandronate Pathway	Desmosterolosis	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Atorvastatin Pathway	3-Methylglutaconic Aciduria Type I	Alendronate Action Pathway	Risedronate Action Pathway	Wolman disease	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Mercaptopurine Action Pathway	Fluvastatin Action Pathway	The oncogenic action of Fumarate	Mitochondrial Electron Transport Chain	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Isovaleric Aciduria
Coenzyme A	HMDB_SMPDB	Samples:	5	Pathways:	69	Isovaleric acidemia	Zoledronate Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	Fluvastatin Pathway	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E3)	Smith-Lemli-Opitz Syndrome (SLOS)	Valine, Leucine and Isoleucine Degradation	Maple Syrup Urine Disease	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Beta-Ketothiolase Deficiency	Mevalonic aciduria	Fatty Acid Elongation In Mitochondria	Rosuvastatin Pathway	Ibandronate Pathway	Carnitine palmitoyl transferase deficiency (I)	Desmosterolosis	Atorvastatin Pathway	3-Methylglutaconic Aciduria Type I	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	The oncogenic action of Fumarate	Lovastatin Pathway	Fatty acid Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Isovaleric Aciduria	Cholesteryl ester storage disease	Steroid Biosynthesis	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Risedronate Pathway	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Congenital lactic acidosis	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Glutaminolysis and Cancer	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Pravastatin Pathway	CHILD Syndrome	Methylmalonic Aciduria	Pamidronate Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Hypercholesterolemia	Alendronate pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Mitochondrial complex II deficiency	Ethylmalonic Encephalopathy	Wolman disease	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	3-hydroxyisobutyric aciduria
Acetoacetyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	62	Isovaleric acidemia	Steroid Biosynthesis	Cholesteryl ester storage disease	Zoledronate Pathway	Glutaric Aciduria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Propionic Acidemia	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Hyper-IgD syndrome	Lovastatin Action Pathway	3-Methylglutaconic Aciduria Type IV	Simvastatin Action Pathway	Cerivastatin Pathway	3-hydroxyisobutyric aciduria	Smith-Lemli-Opitz Syndrome (SLOS)	Valine, Leucine and Isoleucine Degradation	Pamidronate Action Pathway	Lovastatin Pathway	Pravastatin Pathway	Pravastatin Action Pathway	Maple Syrup Urine Disease	CHILD Syndrome	Methylmalonic Aciduria	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Pamidronate Pathway	Rosuvastatin Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Atorvastatin Action Pathway	Beta-Ketothiolase Deficiency	Fatty acid Metabolism	Mevalonic aciduria	Hypercholesterolemia	Cerivastatin Action Pathway	Alendronate pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Ibandronate Action Pathway	Ibandronate Pathway	Carnitine palmitoyl transferase deficiency (I)	Desmosterolosis	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Atorvastatin Pathway	Ethylmalonic Encephalopathy	Wolman disease	Isobutyryl-coa dehydrogenase deficiency	Alendronate Action Pathway	Risedronate Action Pathway	Carnitine palmitoyl transferase deficiency (II)	3-Methylglutaconic Aciduria Type III	Fluvastatin Action Pathway	Trifunctional protein deficiency	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Isovaleric Aciduria
NADH	HMDB_SMPDB	Samples:	5	Pathways:	67	Isovaleric acidemia	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E3)	Valine, Leucine and Isoleucine Degradation	Maple Syrup Urine Disease	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Beta-Ketothiolase Deficiency	Triosephosphate isomerase	Fatty Acid Elongation In Mitochondria	Etoposide Metabolism Pathway	Carnitine palmitoyl transferase deficiency (I)	3-Methylglutaconic Aciduria Type I	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	Mercaptopurine Action Pathway	The oncogenic action of Fumarate	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Fatty acid Metabolism	Fructosuria	Gluconeogenesis	Isovaleric Aciduria	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Glycogenosis, Type IC	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Congenital lactic acidosis	Fructose intolerance, hereditary	Glutaminolysis and Cancer	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Methylmalonic Aciduria	Azathioprine Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Doxorubicin Metabolism Pathway	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Thioguanine Action Pathway	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	Etoposide Action Pathway	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Fanconi-bickel syndrome	Mitochondrial complex II deficiency	Ethylmalonic Encephalopathy	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Mitochondrial Electron Transport Chain	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glycolysis	3-hydroxyisobutyric aciduria
Pyridoxal 5'-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	20	Isovaleric acidemia	Glutaric Aciduria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	Spermidine and Spermine Biosynthesis	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
3-Methylcrotonyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Pyridoxal	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Carbon dioxide	HMDB_SMPDB	Samples:	5	Pathways:	77	Isovaleric acidemia	Zoledronate Pathway	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	Fluvastatin Pathway	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Pentose Phosphate Pathway	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E3)	Smith-Lemli-Opitz Syndrome (SLOS)	Valine, Leucine and Isoleucine Degradation	Maple Syrup Urine Disease	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Beta-Ketothiolase Deficiency	Glucose-6-phosphate dehydrogenase deficiency	Triosephosphate isomerase	Mevalonic aciduria	Ribose-5-phosphate isomerase deficiency	Rosuvastatin Pathway	Ibandronate Pathway	Carnitine palmitoyl transferase deficiency (I)	Desmosterolosis	Atorvastatin Pathway	3-Methylglutaconic Aciduria Type I	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	The oncogenic action of Fumarate	Lovastatin Pathway	Fatty acid Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Gluconeogenesis	Isovaleric Aciduria	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Cholesteryl ester storage disease	Steroid Biosynthesis	Glycogenosis, Type IC	Glutaric Aciduria Type I	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Risedronate Pathway	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Congenital lactic acidosis	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Glutaminolysis and Cancer	Pravastatin Pathway	CHILD Syndrome	Methylmalonic Aciduria	Pamidronate Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Glycogenosis, Type IB	Hypercholesterolemia	Fructose-1,6-diphosphatase deficiency	Alendronate pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Transaldolase deficiency	Mitochondrial complex II deficiency	Ethylmalonic Encephalopathy	Wolman disease	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	Spermidine and Spermine Biosynthesis	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	3-hydroxyisobutyric aciduria
Tiglyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Adenosylcobalamin	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
(S)-b-aminoisobutyric acid	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Molybdopterin	HMDB_SMPDB	Samples:	5	Pathways:	21	Isovaleric acidemia	Doxorubicin Metabolism Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	Thioguanine Action Pathway	3-Methylglutaconic Aciduria Type IV	3-hydroxyisobutyric aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Valine, Leucine and Isoleucine Degradation	3-Methylglutaconic Aciduria Type I	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Mercaptopurine Action Pathway	Methylmalonic Aciduria	Azathioprine Action Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	Isovaleric Aciduria
(S)-Methylmalonic acid semialdehyde	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
R-Methylmalonyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
S-Methylmalonyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Hydrogen peroxide	HMDB_SMPDB	Samples:	5	Pathways:	22	Isovaleric acidemia	Glutaric Aciduria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	Thioguanine Action Pathway	3-Methylglutaconic Aciduria Type IV	3-hydroxyisobutyric aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Valine, Leucine and Isoleucine Degradation	3-Methylglutaconic Aciduria Type I	Isobutyryl-coa dehydrogenase deficiency	Degradation of Superoxides	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Mercaptopurine Action Pathway	Methylmalonic Aciduria	Azathioprine Action Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	Isovaleric Aciduria
3-Methyl-1-hydroxybutyl-ThPP	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
2-Methyl-1-hydroxypropyl-ThPP 	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
S-(3-Methylbutanoyl)-dihydrolipoamide-E	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
S-(2-Methylpropionyl)-dihydrolipoamide-E	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
S-(2-Methylbutanoyl)-dihydrolipoamide	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
3-Hydroxyisovaleryl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Lipoyl-GMP	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Hydrogen Ion	HMDB_SMPDB	Samples:	5	Pathways:	57	Isovaleric acidemia	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glutaric Aciduria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Congenital lactic acidosis	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	3-hydroxyisobutyric aciduria	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Valine, Leucine and Isoleucine Degradation	Degradation of Superoxides	Maple Syrup Urine Disease	Methylmalonic Aciduria	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Beta-Ketothiolase Deficiency	Fatty acid Metabolism	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Fatty Acid Elongation In Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Carnitine palmitoyl transferase deficiency (I)	3-Methylglutaconic Aciduria Type I	Mitochondrial complex II deficiency	Ethylmalonic Encephalopathy	Isobutyryl-coa dehydrogenase deficiency	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	Spermidine and Spermine Biosynthesis	3-Methylglutaconic Aciduria Type III	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Mitochondrial Electron Transport Chain	Trifunctional protein deficiency	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Gluconeogenesis	Isovaleric Aciduria
(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
(R)-Methylmalonyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
(S)-3-Hydroxy-3-methylglutaryl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	40	Isovaleric acidemia	Steroid Biosynthesis	Cholesteryl ester storage disease	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Hyper-IgD syndrome	Lovastatin Action Pathway	3-Methylglutaconic Aciduria Type IV	Simvastatin Action Pathway	3-hydroxyisobutyric aciduria	Valine, Leucine and Isoleucine Degradation	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Pravastatin Action Pathway	Maple Syrup Urine Disease	CHILD Syndrome	Methylmalonic Aciduria	Rosuvastatin Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Atorvastatin Action Pathway	Beta-Ketothiolase Deficiency	Mevalonic aciduria	Hypercholesterolemia	Cerivastatin Action Pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Ibandronate Action Pathway	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Desmosterolosis	Risedronate Action Pathway	3-Methylglutaconic Aciduria Type I	Alendronate Action Pathway	Wolman disease	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Fluvastatin Action Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Isovaleric Aciduria
(S)-3-Hydroxyisobutyrate	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
(S)-Methylmalonate semialdehyde	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
(S)-Methylmalonyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
2-Methyl-1-hydroxypropyl-ThPP	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
2-Methylbut-2-enoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
2-Methylbutanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
2-Methylprop-2-enoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
2-Methylpropanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
2-Oxoglutarate	HMDB_SMPDB	Samples:	5	Pathways:	38	Isovaleric acidemia	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Congenital lactic acidosis	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	3-hydroxyisobutyric aciduria	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Valine, Leucine and Isoleucine Degradation	Maple Syrup Urine Disease	Methylmalonic Aciduria	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Pyruvate dehydrogenase deficiency (E2)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Mitochondrial complex II deficiency	Isobutyryl-coa dehydrogenase deficiency	Fumarase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Gluconeogenesis	Isovaleric Aciduria
3-Methyl-2-oxobutanoic acid	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
3-Methyl-2-oxopentanoate	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
3-Methylbutanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
4-Methyl-2-oxopentanoate	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Acetoacetate	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
ATP	HMDB_SMPDB	Samples:	5	Pathways:	99	Isovaleric acidemia	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Pentose Phosphate Pathway	Lovastatin Action Pathway	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E3)	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Valine, Leucine and Isoleucine Degradation	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Maple Syrup Urine Disease	Rosuvastatin Action Pathway	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Beta-Ketothiolase Deficiency	Glucose-6-phosphate dehydrogenase deficiency	Triosephosphate isomerase	Mevalonic aciduria	Zoledronate Action Pathway	Ribose-5-phosphate isomerase deficiency	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	Carnitine palmitoyl transferase deficiency (I)	Desmosterolosis	Phosphatidylinositol Phosphate Metabolism	Risedronate Action Pathway	3-Methylglutaconic Aciduria Type I	Alendronate Action Pathway	Isobutyryl-coa dehydrogenase deficiency	Joubert syndrome	3-Methylglutaconic Aciduria Type III	Warburg Effect	Mercaptopurine Action Pathway	Fluvastatin Action Pathway	The oncogenic action of Fumarate	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Fatty acid Metabolism	Fructosuria	Gluconeogenesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Isovaleric Aciduria	Cholesteryl ester storage disease	Steroid Biosynthesis	Glycogenosis, Type IC	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Congenital lactic acidosis	Hyper-IgD syndrome	Fructose intolerance, hereditary	Simvastatin Action Pathway	Corticotropin Activation of Cortisol Production	Glutaminolysis and Cancer	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	Pravastatin Action Pathway	CHILD Syndrome	Methylmalonic Aciduria	Azathioprine Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Atorvastatin Action Pathway	Doxorubicin Metabolism Pathway	Glycogenosis, Type IB	Hypercholesterolemia	Cerivastatin Action Pathway	Fructose-1,6-diphosphatase deficiency	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Thioguanine Action Pathway	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ibandronate Action Pathway	Etoposide Action Pathway	The oncogenic action of 2-hydroxyglutarate	Intracellular Signalling Through Histamine H2 Receptor and Histamine	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Transaldolase deficiency	Fanconi-bickel syndrome	Mitochondrial complex II deficiency	Wolman disease	Ethylmalonic Encephalopathy	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	Spermidine and Spermine Biosynthesis	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Mitochondrial Electron Transport Chain	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glycolysis	3-hydroxyisobutyric aciduria
CO2	HMDB_SMPDB	Samples:	5	Pathways:	79	Isovaleric acidemia	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Pentose Phosphate Pathway	Lovastatin Action Pathway	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E3)	Smith-Lemli-Opitz Syndrome (SLOS)	Valine, Leucine and Isoleucine Degradation	Pamidronate Action Pathway	Maple Syrup Urine Disease	Rosuvastatin Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Beta-Ketothiolase Deficiency	Glucose-6-phosphate dehydrogenase deficiency	Triosephosphate isomerase	Mevalonic aciduria	Zoledronate Action Pathway	Ribose-5-phosphate isomerase deficiency	Carnitine palmitoyl transferase deficiency (I)	Desmosterolosis	Risedronate Action Pathway	3-Methylglutaconic Aciduria Type I	Alendronate Action Pathway	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	Mercaptopurine Action Pathway	Fluvastatin Action Pathway	The oncogenic action of Fumarate	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Fatty acid Metabolism	Gluconeogenesis	Isovaleric Aciduria	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Cholesteryl ester storage disease	Steroid Biosynthesis	Glycogenosis, Type IC	Glutaric Aciduria Type I	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Congenital lactic acidosis	Hyper-IgD syndrome	Simvastatin Action Pathway	Glutaminolysis and Cancer	Pravastatin Action Pathway	CHILD Syndrome	Methylmalonic Aciduria	Azathioprine Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Atorvastatin Action Pathway	Glycogenosis, Type IB	Hypercholesterolemia	Fructose-1,6-diphosphatase deficiency	Cerivastatin Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Thioguanine Action Pathway	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ibandronate Action Pathway	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Transaldolase deficiency	Mitochondrial complex II deficiency	Ethylmalonic Encephalopathy	Wolman disease	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	Spermidine and Spermine Biosynthesis	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	3-hydroxyisobutyric aciduria
CoA	HMDB_SMPDB	Samples:	5	Pathways:	67	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Lovastatin Action Pathway	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E3)	Smith-Lemli-Opitz Syndrome (SLOS)	Valine, Leucine and Isoleucine Degradation	Pamidronate Action Pathway	Maple Syrup Urine Disease	Rosuvastatin Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Beta-Ketothiolase Deficiency	Mevalonic aciduria	Fatty Acid Elongation In Mitochondria	Zoledronate Action Pathway	Carnitine palmitoyl transferase deficiency (I)	Desmosterolosis	Risedronate Action Pathway	3-Methylglutaconic Aciduria Type I	Alendronate Action Pathway	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	Fluvastatin Action Pathway	The oncogenic action of Fumarate	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Isovaleric Aciduria	Cholesteryl ester storage disease	Steroid Biosynthesis	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Congenital lactic acidosis	Hyper-IgD syndrome	Simvastatin Action Pathway	Glutaminolysis and Cancer	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Pravastatin Action Pathway	CHILD Syndrome	Methylmalonic Aciduria	Pyruvate dehydrogenase deficiency (E2)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Atorvastatin Action Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Ibandronate Action Pathway	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Mitochondrial complex II deficiency	Ethylmalonic Encephalopathy	Wolman disease	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	3-hydroxyisobutyric aciduria
Cobamide coenzyme	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
H+	HMDB_SMPDB	Samples:	5	Pathways:	55	Isovaleric acidemia	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glutaric Aciduria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Congenital lactic acidosis	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	3-hydroxyisobutyric aciduria	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Valine, Leucine and Isoleucine Degradation	Degradation of Superoxides	Maple Syrup Urine Disease	Methylmalonic Aciduria	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Beta-Ketothiolase Deficiency	Fatty acid Metabolism	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Fatty Acid Elongation In Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Carnitine palmitoyl transferase deficiency (I)	3-Methylglutaconic Aciduria Type I	Mitochondrial complex II deficiency	Ethylmalonic Encephalopathy	Isobutyryl-coa dehydrogenase deficiency	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	Spermidine and Spermine Biosynthesis	3-Methylglutaconic Aciduria Type III	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Mitochondrial Electron Transport Chain	Trifunctional protein deficiency	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Gluconeogenesis	Isovaleric Aciduria
H2O	HMDB_SMPDB	Samples:	5	Pathways:	95	Isovaleric acidemia	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Pentose Phosphate Pathway	Lovastatin Action Pathway	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E3)	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Valine, Leucine and Isoleucine Degradation	Maple Syrup Urine Disease	Rosuvastatin Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Beta-Ketothiolase Deficiency	Glucose-6-phosphate dehydrogenase deficiency	Triosephosphate isomerase	Mevalonic aciduria	Fatty Acid Elongation In Mitochondria	Zoledronate Action Pathway	Ribose-5-phosphate isomerase deficiency	Carnitine palmitoyl transferase deficiency (I)	Desmosterolosis	Phosphatidylinositol Phosphate Metabolism	Risedronate Action Pathway	3-Methylglutaconic Aciduria Type I	Alendronate Action Pathway	Isobutyryl-coa dehydrogenase deficiency	Joubert syndrome	3-Methylglutaconic Aciduria Type III	Warburg Effect	Mercaptopurine Action Pathway	Fluvastatin Action Pathway	The oncogenic action of Fumarate	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Fatty acid Metabolism	Fructosuria	Gluconeogenesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Isovaleric Aciduria	Cholesteryl ester storage disease	Steroid Biosynthesis	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Glycogenosis, Type IC	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Congenital lactic acidosis	Hyper-IgD syndrome	Fructose intolerance, hereditary	Simvastatin Action Pathway	Glutaminolysis and Cancer	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Degradation of Superoxides	Pravastatin Action Pathway	CHILD Syndrome	Methylmalonic Aciduria	Azathioprine Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Atorvastatin Action Pathway	Doxorubicin Metabolism Pathway	Glycogenosis, Type IB	Hypercholesterolemia	Cerivastatin Action Pathway	Fructose-1,6-diphosphatase deficiency	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Thioguanine Action Pathway	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ibandronate Action Pathway	Etoposide Action Pathway	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Transaldolase deficiency	Fanconi-bickel syndrome	Mitochondrial complex II deficiency	Wolman disease	Ethylmalonic Encephalopathy	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	Spermidine and Spermine Biosynthesis	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Mitochondrial Electron Transport Chain	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glycolysis	3-hydroxyisobutyric aciduria
HCO3-	HMDB_SMPDB	Samples:	5	Pathways:	38	Isovaleric acidemia	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Congenital lactic acidosis	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	3-hydroxyisobutyric aciduria	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Valine, Leucine and Isoleucine Degradation	Maple Syrup Urine Disease	Methylmalonic Aciduria	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Pyruvate dehydrogenase deficiency (E2)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Mitochondrial complex II deficiency	Isobutyryl-coa dehydrogenase deficiency	Fumarase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Gluconeogenesis	Isovaleric Aciduria
L-3-Aminoisobutanoate	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
L-Glutamate	HMDB_SMPDB	Samples:	5	Pathways:	24	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	Thioguanine Action Pathway	3-Methylglutaconic Aciduria Type IV	The oncogenic action of 2-hydroxyglutarate	3-hydroxyisobutyric aciduria	Glutaminolysis and Cancer	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Valine, Leucine and Isoleucine Degradation	3-Methylglutaconic Aciduria Type I	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	Maple Syrup Urine Disease	Mercaptopurine Action Pathway	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Methylmalonic Aciduria	Azathioprine Action Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	Isovaleric Aciduria
Methylmalonate	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
NAD+	HMDB_SMPDB	Samples:	5	Pathways:	64	Isovaleric acidemia	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E3)	Valine, Leucine and Isoleucine Degradation	Maple Syrup Urine Disease	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Beta-Ketothiolase Deficiency	Triosephosphate isomerase	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (I)	3-Methylglutaconic Aciduria Type I	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	Mercaptopurine Action Pathway	The oncogenic action of Fumarate	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Fatty acid Metabolism	Fructosuria	Gluconeogenesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Isovaleric Aciduria	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Glycogenosis, Type IC	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Congenital lactic acidosis	Fructose intolerance, hereditary	Glutaminolysis and Cancer	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Methylmalonic Aciduria	Azathioprine Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Doxorubicin Metabolism Pathway	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Thioguanine Action Pathway	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	Etoposide Action Pathway	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Fanconi-bickel syndrome	Mitochondrial complex II deficiency	Ethylmalonic Encephalopathy	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Mitochondrial Electron Transport Chain	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glycolysis	3-hydroxyisobutyric aciduria
Orthophosphate	HMDB_SMPDB	Samples:	5	Pathways:	87	Isovaleric acidemia	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Pentose Phosphate Pathway	Lovastatin Action Pathway	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E3)	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Valine, Leucine and Isoleucine Degradation	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Maple Syrup Urine Disease	Rosuvastatin Action Pathway	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Beta-Ketothiolase Deficiency	Glucose-6-phosphate dehydrogenase deficiency	Triosephosphate isomerase	Mevalonic aciduria	Zoledronate Action Pathway	Ribose-5-phosphate isomerase deficiency	Insulin Signalling	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	Desmosterolosis	Risedronate Action Pathway	Phosphatidylinositol Phosphate Metabolism	3-Methylglutaconic Aciduria Type I	Alendronate Action Pathway	Isobutyryl-coa dehydrogenase deficiency	Joubert syndrome	3-Methylglutaconic Aciduria Type III	Warburg Effect	Mercaptopurine Action Pathway	Fluvastatin Action Pathway	The oncogenic action of Fumarate	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Fructosuria	Gluconeogenesis	Isovaleric Aciduria	Cholesteryl ester storage disease	Steroid Biosynthesis	Glycogenosis, Type IC	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Congenital lactic acidosis	Hyper-IgD syndrome	Fructose intolerance, hereditary	Simvastatin Action Pathway	Glutaminolysis and Cancer	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	Pravastatin Action Pathway	CHILD Syndrome	Methylmalonic Aciduria	Azathioprine Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Atorvastatin Action Pathway	Doxorubicin Metabolism Pathway	Glycogenosis, Type IB	Hypercholesterolemia	Cerivastatin Action Pathway	Fructose-1,6-diphosphatase deficiency	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Thioguanine Action Pathway	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ibandronate Action Pathway	Etoposide Action Pathway	The oncogenic action of 2-hydroxyglutarate	Intracellular Signalling Through Histamine H2 Receptor and Histamine	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Transaldolase deficiency	Fanconi-bickel syndrome	Mitochondrial complex II deficiency	Wolman disease	Fumarase deficiency	Spermidine and Spermine Biosynthesis	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Mitochondrial Electron Transport Chain	Glycolysis	3-hydroxyisobutyric aciduria
Propanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Pyridoxal phosphate	HMDB_SMPDB	Samples:	5	Pathways:	19	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	Spermidine and Spermine Biosynthesis	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
S-(2-Methylpropanoyl)-dihydrolipoamide	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
S-(3-Methylbutanoyl)-dihydrolipoamide	HMDB_SMPDB	Samples:	5	Pathways:	17	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	3-Methylglutaconic Aciduria Type IV	Isovaleric Aciduria	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	Isobutyryl-coa dehydrogenase deficiency	3-Methylglutaconic Aciduria Type III	Maple Syrup Urine Disease	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Succinate	HMDB_SMPDB	Samples:	5	Pathways:	31	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	Congenital lactic acidosis	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	Glutaminolysis and Cancer	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Isovaleric Aciduria	Pyruvate dehydrogenase deficiency (E3)	Valine, Leucine and Isoleucine Degradation	3-Methylglutaconic Aciduria Type I	Mitochondrial complex II deficiency	Isobutyryl-coa dehydrogenase deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Fumarase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	Maple Syrup Urine Disease	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Methylmalonic Aciduria	Mitochondrial Electron Transport Chain	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
Thiamin diphosphate	HMDB_SMPDB	Samples:	5	Pathways:	30	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Propionic Acidemia	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	Congenital lactic acidosis	3-Methylglutaconic Aciduria Type IV	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	Glutaminolysis and Cancer	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Isovaleric Aciduria	Pyruvate dehydrogenase deficiency (E3)	Valine, Leucine and Isoleucine Degradation	3-Methylglutaconic Aciduria Type I	Mitochondrial complex II deficiency	Isobutyryl-coa dehydrogenase deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Fumarase deficiency	3-Methylglutaconic Aciduria Type III	Warburg Effect	Maple Syrup Urine Disease	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Methylmalonic Aciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Pyruvate dehydrogenase deficiency (E2)	Beta-Ketothiolase Deficiency	3-hydroxyisobutyric aciduria
D-Glucose	HMDB_SMPDB	Samples:	5	Pathways:	13	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Warburg Effect	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycolysis	Insulin Signalling	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease
Pyrophosphate	HMDB_SMPDB	Samples:	5	Pathways:	49	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin 	Hyper-IgD syndrome	Fructose intolerance, hereditary	Simvastatin Action Pathway	Corticotropin Activation of Cortisol Production	Cerivastatin Pathway	Fructose and Mannose Degradation	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Smith-Lemli-Opitz Syndrome (SLOS)	Pravastatin Pathway	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	CHILD Syndrome	Pamidronate Pathway	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Mevalonic aciduria	Hypercholesterolemia	Alendronate pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	Intracellular Signalling Through Histamine H2 Receptor and Histamine	Ibandronate Pathway	Desmosterolosis	Carnitine palmitoyl transferase deficiency (I)	Atorvastatin Pathway	Ethylmalonic Encephalopathy	Wolman disease	Carnitine palmitoyl transferase deficiency (II)	Spermidine and Spermine Biosynthesis	Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin 	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	Trifunctional protein deficiency	Lovastatin Pathway	Fatty acid Metabolism	Fructosuria	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)
Uridine 5'-diphosphate	HMDB_SMPDB	Samples:	1	Pathways:	1	Etoposide Metabolism Pathway
Magnesium	HMDB_SMPDB	Samples:	5	Pathways:	84	Zoledronate Pathway	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Fluvastatin Pathway	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Pentose Phosphate Pathway	Citric Acid Cycle	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E3)	Smith-Lemli-Opitz Syndrome (SLOS)	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Glucose-6-phosphate dehydrogenase deficiency	Triosephosphate isomerase	Etoposide Metabolism Pathway	Ribose-5-phosphate isomerase deficiency	Rosuvastatin Pathway	Adefovir Dipivoxil Metabolism Pathway	Insulin Signalling	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	Ibandronate Pathway	Carnitine palmitoyl transferase deficiency (I)	Desmosterolosis	Atorvastatin Pathway	Phosphatidylinositol Phosphate Metabolism	Joubert syndrome	Warburg Effect	The oncogenic action of Fumarate	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	Lovastatin Pathway	Fatty acid Metabolism	Gluconeogenesis	Fructosuria	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Cholesteryl ester storage disease	Steroid Biosynthesis	Glycogenosis, Type IC	Glutaric Aciduria Type I	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Risedronate Pathway	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Congenital lactic acidosis	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin 	Hyper-IgD syndrome	Fructose intolerance, hereditary	Simvastatin Action Pathway	Corticotropin Activation of Cortisol Production	Cerivastatin Pathway	Glutaminolysis and Cancer	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Pravastatin Pathway	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	CHILD Syndrome	Pamidronate Pathway	Pyruvate dehydrogenase deficiency (E2)	Tenofovir Metabolism Pathway	Glycogenosis, Type IB	Hypercholesterolemia	Fructose-1,6-diphosphatase deficiency	Alendronate pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	Intracellular Signalling Through Histamine H2 Receptor and Histamine	Transaldolase deficiency	Fanconi-bickel syndrome	Mitochondrial complex II deficiency	Ethylmalonic Encephalopathy	Wolman disease	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	Spermidine and Spermine Biosynthesis	Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Trifunctional protein deficiency	Fc Epsilon Receptor I Signaling in Mast Cells	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glycolysis	Mevalonic aciduria
Zinc (II) ion	HMDB_SMPDB	Samples:	5	Pathways:	4	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Degradation of Superoxides
Manganese	HMDB_SMPDB	Samples:	5	Pathways:	26	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Congenital lactic acidosis	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Phosphatidylinositol Phosphate Metabolism	Mitochondrial complex II deficiency	Degradation of Superoxides	Joubert syndrome	Fumarase deficiency	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Fc Epsilon Receptor I Signaling in Mast Cells	Gluconeogenesis	Pyruvate dehydrogenase deficiency (E2)
Glucose 1-phosphate	HMDB_SMPDB	Samples:	4	Pathways:	11	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycolysis	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease
Phosphoric acid	HMDB_SMPDB	Samples:	5	Pathways:	15	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Gluconeogenesis	Glycogenosis, Type IA. Von gierke disease	Warburg Effect	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Fructose intolerance, hereditary	Glycolysis	Fructosuria	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease
Iron	HMDB_SMPDB	Samples:	3	Pathways:	34	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Hyper-IgD syndrome	Lovastatin Action Pathway	Simvastatin Action Pathway	Cerivastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Pravastatin Pathway	Pravastatin Action Pathway	CHILD Syndrome	Rosuvastatin Action Pathway	Pamidronate Pathway	Atorvastatin Action Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Alendronate pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Ibandronate Action Pathway	Ibandronate Pathway	Desmosterolosis	Risedronate Action Pathway	Atorvastatin Pathway	Alendronate Action Pathway	Wolman disease	Fluvastatin Action Pathway	Lovastatin Pathway	Mevalonic aciduria
Calcium cation	HMDB_SMPDB	Samples:	4	Pathways:	8	Phosphatidylinositol Phosphate Metabolism	Joubert syndrome	Mercaptopurine Action Pathway	Thioguanine Action Pathway	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	Azathioprine Action Pathway	Fc Epsilon Receptor I Signaling in Mast Cells	Etoposide Action Pathway
D-Glucose 1-phosphate	HMDB_SMPDB	Samples:	4	Pathways:	11	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycolysis	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease
Diphosphate	HMDB_SMPDB	Samples:	5	Pathways:	49	Cholesteryl ester storage disease	Steroid Biosynthesis	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Hyper-IgD syndrome	Fructose intolerance, hereditary	Lovastatin Action Pathway	Simvastatin Action Pathway	Corticotropin Activation of Cortisol Production	Fructose and Mannose Degradation	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	Pravastatin Action Pathway	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	CHILD Syndrome	Rosuvastatin Action Pathway	Azathioprine Action Pathway	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Atorvastatin Action Pathway	Mevalonic aciduria	Hypercholesterolemia	Cerivastatin Action Pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Thioguanine Action Pathway	Ibandronate Action Pathway	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	Intracellular Signalling Through Histamine H2 Receptor and Histamine	Desmosterolosis	Carnitine palmitoyl transferase deficiency (I)	Risedronate Action Pathway	Alendronate Action Pathway	Ethylmalonic Encephalopathy	Wolman disease	Carnitine palmitoyl transferase deficiency (II)	Spermidine and Spermine Biosynthesis	Mercaptopurine Action Pathway	Fluvastatin Action Pathway	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	Trifunctional protein deficiency	Fatty acid Metabolism	Fructosuria	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)
Magnesium cation	HMDB_SMPDB	Samples:	5	Pathways:	81	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Pentose Phosphate Pathway	Lovastatin Action Pathway	Citric Acid Cycle	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E3)	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Rosuvastatin Action Pathway	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Glucose-6-phosphate dehydrogenase deficiency	Triosephosphate isomerase	Zoledronate Action Pathway	Ribose-5-phosphate isomerase deficiency	Insulin Signalling	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	Carnitine palmitoyl transferase deficiency (I)	Desmosterolosis	Risedronate Action Pathway	Phosphatidylinositol Phosphate Metabolism	Alendronate Action Pathway	Joubert syndrome	Warburg Effect	Mercaptopurine Action Pathway	Fluvastatin Action Pathway	The oncogenic action of Fumarate	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	Fatty acid Metabolism	Fructosuria	Gluconeogenesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Cholesteryl ester storage disease	Steroid Biosynthesis	Glycogenosis, Type IC	Glutaric Aciduria Type I	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Congenital lactic acidosis	Hyper-IgD syndrome	Fructose intolerance, hereditary	Simvastatin Action Pathway	Corticotropin Activation of Cortisol Production	Glutaminolysis and Cancer	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	Pravastatin Action Pathway	CHILD Syndrome	Azathioprine Action Pathway	Pyruvate dehydrogenase deficiency (E2)	Atorvastatin Action Pathway	Glycogenosis, Type IB	Hypercholesterolemia	Fructose-1,6-diphosphatase deficiency	Cerivastatin Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Thioguanine Action Pathway	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ibandronate Action Pathway	The oncogenic action of 2-hydroxyglutarate	Etoposide Action Pathway	Intracellular Signalling Through Histamine H2 Receptor and Histamine	Transaldolase deficiency	Fanconi-bickel syndrome	Mitochondrial complex II deficiency	Ethylmalonic Encephalopathy	Wolman disease	Carnitine palmitoyl transferase deficiency (II)	Fumarase deficiency	Spermidine and Spermine Biosynthesis	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Trifunctional protein deficiency	Fc Epsilon Receptor I Signaling in Mast Cells	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glycolysis	Mevalonic aciduria
Manganese(2+)	HMDB_SMPDB	Samples:	5	Pathways:	25	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Congenital lactic acidosis	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Phosphatidylinositol Phosphate Metabolism	Mitochondrial complex II deficiency	Degradation of Superoxides	Joubert syndrome	Fumarase deficiency	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Fc Epsilon Receptor I Signaling in Mast Cells	Gluconeogenesis	Pyruvate dehydrogenase deficiency (E2)
UDP	HMDB_SMPDB	Samples:	1	Pathways:	1	Etoposide Action Pathway
Zinc cation	HMDB_SMPDB	Samples:	5	Pathways:	7	Azathioprine Action Pathway	Fructose intolerance, hereditary	Degradation of Superoxides	Fructosuria	Fructose and Mannose Degradation	Thioguanine Action Pathway	Mercaptopurine Action Pathway
7-Dehydrocholesterol	HMDB_SMPDB	Samples:	3	Pathways:	34	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Hyper-IgD syndrome	Lovastatin Action Pathway	Simvastatin Action Pathway	Cerivastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Pravastatin Pathway	Pravastatin Action Pathway	CHILD Syndrome	Rosuvastatin Action Pathway	Pamidronate Pathway	Atorvastatin Action Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Alendronate pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Ibandronate Action Pathway	Ibandronate Pathway	Desmosterolosis	Risedronate Action Pathway	Atorvastatin Pathway	Alendronate Action Pathway	Wolman disease	Fluvastatin Action Pathway	Lovastatin Pathway	Mevalonic aciduria
Cholesterol	HMDB_SMPDB	Samples:	3	Pathways:	34	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Hyper-IgD syndrome	Lovastatin Action Pathway	Simvastatin Action Pathway	Cerivastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Pravastatin Pathway	Pravastatin Action Pathway	CHILD Syndrome	Rosuvastatin Action Pathway	Pamidronate Pathway	Atorvastatin Action Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Alendronate pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Ibandronate Action Pathway	Ibandronate Pathway	Desmosterolosis	Risedronate Action Pathway	Atorvastatin Pathway	Alendronate Action Pathway	Wolman disease	Fluvastatin Action Pathway	Lovastatin Pathway	Mevalonic aciduria
Formic acid	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
NADP	HMDB_SMPDB	Samples:	5	Pathways:	42	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Glutaric Aciduria Type I	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	The oncogenic action of Succinate	Risedronate Pathway	Fluvastatin Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Pentose Phosphate Pathway	Fructose intolerance, hereditary	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Fructose and Mannose Degradation	Glutaminolysis and Cancer	Smith-Lemli-Opitz Syndrome (SLOS)	Degradation of Superoxides	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Glucose-6-phosphate dehydrogenase deficiency	Doxorubicin Metabolism Pathway	Hypercholesterolemia	Fatty Acid Elongation In Mitochondria	Alendronate pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Ribose-5-phosphate isomerase deficiency	Rosuvastatin Pathway	The oncogenic action of 2-hydroxyglutarate	Ibandronate Pathway	Desmosterolosis	Transaldolase deficiency	Atorvastatin Pathway	Wolman disease	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Lovastatin Pathway	Fructosuria	Mevalonic aciduria
NADPH	HMDB_SMPDB	Samples:	5	Pathways:	55	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Glutaric Aciduria Type I	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	The oncogenic action of Succinate	Risedronate Pathway	Fluvastatin Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Pentose Phosphate Pathway	Fructose intolerance, hereditary	Hyper-IgD syndrome	Simvastatin Action Pathway	Lovastatin Action Pathway	Cerivastatin Pathway	Fructose and Mannose Degradation	Glutaminolysis and Cancer	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Pravastatin Pathway	Pravastatin Action Pathway	CHILD Syndrome	Rosuvastatin Action Pathway	Pamidronate Pathway	Azathioprine Action Pathway	Atorvastatin Action Pathway	Glucose-6-phosphate dehydrogenase deficiency	Doxorubicin Metabolism Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Fatty Acid Elongation In Mitochondria	Alendronate pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Thioguanine Action Pathway	Ribose-5-phosphate isomerase deficiency	Rosuvastatin Pathway	Ibandronate Action Pathway	The oncogenic action of 2-hydroxyglutarate	Ibandronate Pathway	Desmosterolosis	Transaldolase deficiency	Atorvastatin Pathway	Risedronate Action Pathway	Alendronate Action Pathway	Wolman disease	Warburg Effect	Mercaptopurine Action Pathway	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Fluvastatin Action Pathway	Lovastatin Pathway	Fructosuria	Mevalonic aciduria
Mevalonic acid	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
Squalene	HMDB_SMPDB	Samples:	3	Pathways:	34	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Hyper-IgD syndrome	Lovastatin Action Pathway	Simvastatin Action Pathway	Cerivastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Pravastatin Pathway	Pravastatin Action Pathway	CHILD Syndrome	Rosuvastatin Action Pathway	Pamidronate Pathway	Atorvastatin Action Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Alendronate pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Ibandronate Action Pathway	Ibandronate Pathway	Desmosterolosis	Risedronate Action Pathway	Atorvastatin Pathway	Alendronate Action Pathway	Wolman disease	Fluvastatin Action Pathway	Lovastatin Pathway	Mevalonic aciduria
Vitamin D3	HMDB_SMPDB	Samples:	3	Pathways:	34	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Hyper-IgD syndrome	Lovastatin Action Pathway	Simvastatin Action Pathway	Cerivastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Pravastatin Pathway	Pravastatin Action Pathway	CHILD Syndrome	Rosuvastatin Action Pathway	Pamidronate Pathway	Atorvastatin Action Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Alendronate pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Ibandronate Action Pathway	Ibandronate Pathway	Desmosterolosis	Risedronate Action Pathway	Atorvastatin Pathway	Alendronate Action Pathway	Wolman disease	Fluvastatin Action Pathway	Lovastatin Pathway	Mevalonic aciduria
Farnesyl pyrophosphate	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
4,4-Dimethylcholesta-8,14,24-trienol	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
(S)-5-Diphosphomevalonic acid	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
Dimethylallylpyrophosphate	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
Lathosterol	HMDB_SMPDB	Samples:	3	Pathways:	34	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Hyper-IgD syndrome	Lovastatin Action Pathway	Simvastatin Action Pathway	Cerivastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Pravastatin Pathway	Pravastatin Action Pathway	CHILD Syndrome	Rosuvastatin Action Pathway	Pamidronate Pathway	Atorvastatin Action Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Alendronate pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Ibandronate Action Pathway	Ibandronate Pathway	Desmosterolosis	Risedronate Action Pathway	Atorvastatin Pathway	Alendronate Action Pathway	Wolman disease	Fluvastatin Action Pathway	Lovastatin Pathway	Mevalonic aciduria
(S)-2,3-Epoxysqualene	HMDB_SMPDB	Samples:	3	Pathways:	34	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Hyper-IgD syndrome	Lovastatin Action Pathway	Simvastatin Action Pathway	Cerivastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Pravastatin Pathway	Pravastatin Action Pathway	CHILD Syndrome	Rosuvastatin Action Pathway	Pamidronate Pathway	Atorvastatin Action Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Alendronate pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Ibandronate Action Pathway	Ibandronate Pathway	Desmosterolosis	Risedronate Action Pathway	Atorvastatin Pathway	Alendronate Action Pathway	Wolman disease	Fluvastatin Action Pathway	Lovastatin Pathway	Mevalonic aciduria
4a-Methylzymosterol	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
Lanosterin	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
Geranyl-PP	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
4,4-Dimethyl-5a-cholesta-8,24-dien-3-b-ol	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
Mevalonic acid-5P	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
Isopentenyl pyrophosphate	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
8-Dehydrocholesterol	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
Desmosterol	HMDB_SMPDB	Samples:	3	Pathways:	34	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Hyper-IgD syndrome	Lovastatin Action Pathway	Simvastatin Action Pathway	Cerivastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Pravastatin Pathway	Pravastatin Action Pathway	CHILD Syndrome	Rosuvastatin Action Pathway	Pamidronate Pathway	Atorvastatin Action Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Alendronate pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Ibandronate Action Pathway	Ibandronate Pathway	Desmosterolosis	Risedronate Action Pathway	Atorvastatin Pathway	Alendronate Action Pathway	Wolman disease	Fluvastatin Action Pathway	Lovastatin Pathway	Mevalonic aciduria
Heme	HMDB_SMPDB	Samples:	5	Pathways:	42	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Hyper-IgD syndrome	Lovastatin Action Pathway	Simvastatin Action Pathway	Cerivastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Degradation of Superoxides	Pravastatin Pathway	Pravastatin Action Pathway	CHILD Syndrome	Rosuvastatin Action Pathway	Pamidronate Pathway	Azathioprine Action Pathway	Atorvastatin Action Pathway	Doxorubicin Metabolism Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Alendronate pathway	Etoposide Metabolism Pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Thioguanine Action Pathway	Rosuvastatin Pathway	Ibandronate Action Pathway	Etoposide Action Pathway	Ibandronate Pathway	Desmosterolosis	Risedronate Action Pathway	Atorvastatin Pathway	Alendronate Action Pathway	Wolman disease	Mercaptopurine Action Pathway	Fluvastatin Action Pathway	Mitochondrial Electron Transport Chain	Lovastatin Pathway	Mevalonic aciduria
7-Dehydrodesmosterol	HMDB_SMPDB	Samples:	3	Pathways:	34	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Hyper-IgD syndrome	Lovastatin Action Pathway	Simvastatin Action Pathway	Cerivastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Pravastatin Pathway	Pravastatin Action Pathway	CHILD Syndrome	Rosuvastatin Action Pathway	Pamidronate Pathway	Atorvastatin Action Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Alendronate pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Ibandronate Action Pathway	Ibandronate Pathway	Desmosterolosis	Risedronate Action Pathway	Atorvastatin Pathway	Alendronate Action Pathway	Wolman disease	Fluvastatin Action Pathway	Lovastatin Pathway	Mevalonic aciduria
Zymosterol intermediate 2	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
3-Keto-4-methylzymosterol	HMDB_SMPDB	Samples:	3	Pathways:	34	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Hyper-IgD syndrome	Lovastatin Action Pathway	Simvastatin Action Pathway	Cerivastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Pravastatin Pathway	Pravastatin Action Pathway	CHILD Syndrome	Rosuvastatin Action Pathway	Pamidronate Pathway	Atorvastatin Action Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Alendronate pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Ibandronate Action Pathway	Ibandronate Pathway	Desmosterolosis	Risedronate Action Pathway	Atorvastatin Pathway	Alendronate Action Pathway	Wolman disease	Fluvastatin Action Pathway	Lovastatin Pathway	Mevalonic aciduria
24,25-Dihydrolanosterol	HMDB_SMPDB	Samples:	3	Pathways:	34	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Hyper-IgD syndrome	Lovastatin Action Pathway	Simvastatin Action Pathway	Cerivastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Pravastatin Pathway	Pravastatin Action Pathway	CHILD Syndrome	Rosuvastatin Action Pathway	Pamidronate Pathway	Atorvastatin Action Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Alendronate pathway	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Ibandronate Action Pathway	Ibandronate Pathway	Desmosterolosis	Risedronate Action Pathway	Atorvastatin Pathway	Alendronate Action Pathway	Wolman disease	Fluvastatin Action Pathway	Lovastatin Pathway	Mevalonic aciduria
4,4-Dimethyl-5a-cholesta-8-en-3b-ol	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
5a-Cholest-8-en-3b-ol	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
5a-Cholesta-7,24-dien-3b-ol	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
4a-Methylzymosterol-4-carboxylic acid	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Zoledronate Pathway	Hypercholesterolemia	Alendronate pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Fluvastatin Pathway	Risedronate Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Rosuvastatin Pathway	Hyper-IgD syndrome	Simvastatin Action Pathway	Cerivastatin Pathway	Ibandronate Pathway	Desmosterolosis	Atorvastatin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Wolman disease	Pravastatin Pathway	CHILD Syndrome	Pamidronate Pathway	Lovastatin Pathway	Mevalonic aciduria
Ammonia	HMDB_SMPDB	Samples:	5	Pathways:	8	Warburg Effect	Mercaptopurine Action Pathway	Thioguanine Action Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Azathioprine Action Pathway	The oncogenic action of 2-hydroxyglutarate	Glutaminolysis and Cancer
Fructose 6-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	19	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Fructosuria	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Fructose intolerance, hereditary	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Transaldolase deficiency	Fanconi-bickel syndrome	Warburg Effect	Glycolysis	Gluconeogenesis	Glucose-6-phosphate dehydrogenase deficiency
Pyruvic acid	HMDB_SMPDB	Samples:	5	Pathways:	25	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Congenital lactic acidosis	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Gluconeogenesis	Glutaminolysis and Cancer	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E3)	Fanconi-bickel syndrome	Mitochondrial complex II deficiency	Fumarase deficiency	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Glycolysis	Pyruvate dehydrogenase deficiency (E2)
Phosphoenolpyruvic acid	HMDB_SMPDB	Samples:	5	Pathways:	12	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Warburg Effect	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycolysis	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease
L-Glutamine	HMDB_SMPDB	Samples:	5	Pathways:	8	Warburg Effect	Mercaptopurine Action Pathway	Thioguanine Action Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Azathioprine Action Pathway	The oncogenic action of 2-hydroxyglutarate	Glutaminolysis and Cancer
D-Fructose	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
beta-D-Fructose	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
D-Fructose 6-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	19	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Fructosuria	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Fructose intolerance, hereditary	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Transaldolase deficiency	Fanconi-bickel syndrome	Warburg Effect	Glycolysis	Gluconeogenesis	Glucose-6-phosphate dehydrogenase deficiency
Phosphoenolpyruvate	HMDB_SMPDB	Samples:	5	Pathways:	12	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Warburg Effect	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycolysis	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease
Pyruvate	HMDB_SMPDB	Samples:	5	Pathways:	24	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Congenital lactic acidosis	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Gluconeogenesis	Glutaminolysis and Cancer	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E3)	Fanconi-bickel syndrome	Mitochondrial complex II deficiency	Fumarase deficiency	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Glycolysis	Pyruvate dehydrogenase deficiency (E2)
Formaldehyde	HMDB_SMPDB	Samples:	1	Pathways:	2	Etoposide Metabolism Pathway	Etoposide Action Pathway
L-Carnitine	HMDB_SMPDB	Samples:	5	Pathways:	12	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
Dodecanoic acid	HMDB_SMPDB	Samples:	1	Pathways:	1	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids
Tetradecanoyl-CoA 	HMDB_SMPDB	Samples:	5	Pathways:	13	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
Lauroyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	14	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
Tetradecanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
NADP+	HMDB_SMPDB	Samples:	5	Pathways:	43	Cholesteryl ester storage disease	Steroid Biosynthesis	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	The oncogenic action of Succinate	Pentose Phosphate Pathway	Fructose intolerance, hereditary	Hyper-IgD syndrome	Simvastatin Action Pathway	Lovastatin Action Pathway	Fructose and Mannose Degradation	Glutaminolysis and Cancer	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Degradation of Superoxides	Pravastatin Action Pathway	CHILD Syndrome	Rosuvastatin Action Pathway	Azathioprine Action Pathway	Atorvastatin Action Pathway	Glucose-6-phosphate dehydrogenase deficiency	Doxorubicin Metabolism Pathway	Hypercholesterolemia	Cerivastatin Action Pathway	Fatty Acid Elongation In Mitochondria	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Thioguanine Action Pathway	Ribose-5-phosphate isomerase deficiency	Ibandronate Action Pathway	The oncogenic action of 2-hydroxyglutarate	Desmosterolosis	Transaldolase deficiency	Risedronate Action Pathway	Alendronate Action Pathway	Wolman disease	Warburg Effect	Mercaptopurine Action Pathway	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Fluvastatin Action Pathway	Fructosuria	Mevalonic aciduria
Inositol 1,4,5-trisphosphate	HMDB_SMPDB	Samples:	2	Pathways:	3	Phosphatidylinositol Phosphate Metabolism	Joubert syndrome	Fc Epsilon Receptor I Signaling in Mast Cells
Potassium cation	HMDB_SMPDB	Samples:	5	Pathways:	8	Fanconi-bickel syndrome	Spermidine and Spermine Biosynthesis	Warburg Effect	Mercaptopurine Action Pathway	Thioguanine Action Pathway	Azathioprine Action Pathway	Glycolysis	Glycogenosis, Type VII. Tarui disease
Sodium cation	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Uridine diphosphate glucuronic acid	HMDB_SMPDB	Samples:	1	Pathways:	1	Etoposide Metabolism Pathway
Arachidonic acid	HMDB_SMPDB	Samples:	2	Pathways:	1	Fc Epsilon Receptor I Signaling in Mast Cells
Leukotriene C4	HMDB_SMPDB	Samples:	2	Pathways:	1	Fc Epsilon Receptor I Signaling in Mast Cells
Prostaglandin I2	HMDB_SMPDB	Samples:	2	Pathways:	1	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin
Prostaglandin D2	HMDB_SMPDB	Samples:	2	Pathways:	1	Fc Epsilon Receptor I Signaling in Mast Cells
Fe3+	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Arachidonate	HMDB_SMPDB	Samples:	2	Pathways:	1	Fc Epsilon Receptor I Signaling in Mast Cells
Tetrahydrobiopterin	HMDB_SMPDB	Samples:	1	Pathways:	1	Doxorubicin Metabolism Pathway
Adenosine monophosphate	HMDB_SMPDB	Samples:	5	Pathways:	17	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Carnitine palmitoyl transferase deficiency (I)	Transaldolase deficiency	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Carnitine palmitoyl transferase deficiency (II)	Fatty acid Metabolism	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glucose-6-phosphate dehydrogenase deficiency	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)
Glycine	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Fumaric acid	HMDB_SMPDB	Samples:	5	Pathways:	15	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	Warburg Effect	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial Electron Transport Chain	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E2)	Glutaminolysis and Cancer
L-Proline	HMDB_SMPDB	Samples:	5	Pathways:	2	The oncogenic action of Fumarate	The oncogenic action of Succinate
L-Aspartic acid	HMDB_SMPDB	Samples:	5	Pathways:	1	Glutaminolysis and Cancer
Ornithine	HMDB_SMPDB	Samples:	5	Pathways:	1	Spermidine and Spermine Biosynthesis
Oxalacetic acid	HMDB_SMPDB	Samples:	5	Pathways:	22	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Congenital lactic acidosis	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Gluconeogenesis	Pyruvate dehydrogenase deficiency (E2)
S-Adenosylmethionine	HMDB_SMPDB	Samples:	5	Pathways:	1	Spermidine and Spermine Biosynthesis
Flavin Mononucleotide	HMDB_SMPDB	Samples:	1	Pathways:	1	Doxorubicin Metabolism Pathway
AMP	HMDB_SMPDB	Samples:	5	Pathways:	19	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Thioguanine Action Pathway	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Carnitine palmitoyl transferase deficiency (I)	Transaldolase deficiency	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Carnitine palmitoyl transferase deficiency (II)	Fatty acid Metabolism	Mercaptopurine Action Pathway	Azathioprine Action Pathway	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glucose-6-phosphate dehydrogenase deficiency	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)
FMN	HMDB_SMPDB	Samples:	1	Pathways:	1	Doxorubicin Metabolism Pathway
Fumarate	HMDB_SMPDB	Samples:	5	Pathways:	17	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	Thioguanine Action Pathway	Congenital lactic acidosis	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	Warburg Effect	Mercaptopurine Action Pathway	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Mitochondrial Electron Transport Chain	Azathioprine Action Pathway	Pyruvate dehydrogenase deficiency (E2)
L-Aspartate	HMDB_SMPDB	Samples:	5	Pathways:	4	Thioguanine Action Pathway	Glutaminolysis and Cancer	Mercaptopurine Action Pathway	Azathioprine Action Pathway
L-Ornithine	HMDB_SMPDB	Samples:	5	Pathways:	1	Spermidine and Spermine Biosynthesis
Oxaloacetate	HMDB_SMPDB	Samples:	5	Pathways:	21	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Congenital lactic acidosis	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Gluconeogenesis	Pyruvate dehydrogenase deficiency (E2)
S-Adenosyl-L-homocysteine	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
S-Adenosyl-L-methionine	HMDB_SMPDB	Samples:	5	Pathways:	4	Thioguanine Action Pathway	Spermidine and Spermine Biosynthesis	Azathioprine Action Pathway	Mercaptopurine Action Pathway
UDP-glucuronate	HMDB_SMPDB	Samples:	1	Pathways:	1	Etoposide Action Pathway
L-Alanine	HMDB_SMPDB	Samples:	5	Pathways:	1	Glutaminolysis and Cancer
Palmitic acid	HMDB_SMPDB	Samples:	5	Pathways:	12	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
L-Palmitoylcarnitine	HMDB_SMPDB	Samples:	5	Pathways:	10	Ethylmalonic Encephalopathy	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
Octanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	14	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
Butyryl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
3-Hydroxybutyryl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	11	Ethylmalonic Encephalopathy	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
Palmityl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
Glutaryl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	10	Ethylmalonic Encephalopathy	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
Crotonoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	11	Ethylmalonic Encephalopathy	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
(S)-3-Hydroxyhexadecanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
(S)-3-Hydroxytetradecanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
3-Oxotetradecanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
(S)-3-Hydroxydodecanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
3-Oxododecanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
(S)-Hydroxydecanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
3-Oxodecanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
(S)-Hydroxyoctanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	14	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
3-Oxooctanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	14	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
(S)-Hydroxyhexanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
3-Oxohexanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
trans-2-Hexenoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	14	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
(2E)-Hexadecenoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
(2E)-Tetradecenoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
(2E)-Decenoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
(2E)-Octenoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	14	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
3-Oxohexadecanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
Decanoyl-CoA (n-C10:0CoA)	HMDB_SMPDB	Samples:	5	Pathways:	13	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
(R)-3-Hydroxybutanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	11	Ethylmalonic Encephalopathy	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
(S)-3-Hydroxyoctanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	12	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
3-Oxopalmitoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
Butanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
Decanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	12	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
Hexadecanoic acid	HMDB_SMPDB	Samples:	5	Pathways:	12	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
Hexanoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	14	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
Palmitoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
trans-Dec-2-enoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	12	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
trans-Hex-2-enoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
trans-Hexadec-2-enoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
trans-Oct-2-enoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	12	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
trans-Tetradec-2-enoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	13	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Ethylmalonic Encephalopathy	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Carnitine palmitoyl transferase deficiency (II)	Glutaric Aciduria Type I	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Trifunctional protein deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Fatty acid Metabolism	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine palmitoyl transferase deficiency (I)
Etoposide	HMDB_SMPDB	Samples:	1	Pathways:	2	Etoposide Metabolism Pathway	Etoposide Action Pathway
Cyclic AMP	HMDB_SMPDB	Samples:	5	Pathways:	9	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Corticotropin Activation of Cortisol Production	Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin 	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin 	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Intracellular Signalling Through Histamine H2 Receptor and Histamine	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone
Guanosine diphosphate	HMDB_SMPDB	Samples:	5	Pathways:	32	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Congenital lactic acidosis	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin 	Citric Acid Cycle	Corticotropin Activation of Cortisol Production	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Pyruvate dehydrogenase deficiency (E2)	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	Insulin Signalling	Intracellular Signalling Through Histamine H2 Receptor and Histamine	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	Mitochondrial complex II deficiency	Fumarase deficiency	Warburg Effect	Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	Gluconeogenesis
Guanosine triphosphate	HMDB_SMPDB	Samples:	5	Pathways:	35	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Fructosuria	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Congenital lactic acidosis	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin 	Fructose intolerance, hereditary	Citric Acid Cycle	Corticotropin Activation of Cortisol Production	Fructose and Mannose Degradation	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Pyruvate dehydrogenase deficiency (E2)	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	Insulin Signalling	Intracellular Signalling Through Histamine H2 Receptor and Histamine	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	Mitochondrial complex II deficiency	Fumarase deficiency	Warburg Effect	Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	Gluconeogenesis
3',5'-Cyclic AMP	HMDB_SMPDB	Samples:	5	Pathways:	10	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Corticotropin Activation of Cortisol Production	Mercaptopurine Action Pathway	Thioguanine Action Pathway	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	Azathioprine Action Pathway	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Intracellular Signalling Through Histamine H2 Receptor and Histamine	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone
GDP	HMDB_SMPDB	Samples:	5	Pathways:	32	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Congenital lactic acidosis	Citric Acid Cycle	Corticotropin Activation of Cortisol Production	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Azathioprine Action Pathway	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Pyruvate dehydrogenase deficiency (E2)	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Thioguanine Action Pathway	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	Insulin Signalling	Intracellular Signalling Through Histamine H2 Receptor and Histamine	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	Mitochondrial complex II deficiency	Fumarase deficiency	Warburg Effect	Mercaptopurine Action Pathway	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	Gluconeogenesis
GTP	HMDB_SMPDB	Samples:	5	Pathways:	35	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Fructosuria	The oncogenic action of Succinate	Glycogenosis, Type IA. Von gierke disease	2-ketoglutarate dehydrogenase complex deficiency	Congenital lactic acidosis	Fructose intolerance, hereditary	Citric Acid Cycle	Corticotropin Activation of Cortisol Production	Fructose and Mannose Degradation	Glutaminolysis and Cancer	Pyruvate dehydrogenase deficiency (E3)	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Azathioprine Action Pathway	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Pyruvate dehydrogenase deficiency (E2)	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Thioguanine Action Pathway	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of 2-hydroxyglutarate	Insulin Signalling	Intracellular Signalling Through Histamine H2 Receptor and Histamine	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	Mitochondrial complex II deficiency	Fumarase deficiency	Warburg Effect	Mercaptopurine Action Pathway	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of Fumarate	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	Gluconeogenesis
Beta-D-Glucose	HMDB_SMPDB	Samples:	4	Pathways:	11	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycolysis	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease
Hydrogen	HMDB_SMPDB	Samples:	5	Pathways:	6	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Mitochondrial Electron Transport Chain	Degradation of Superoxides	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Warburg Effect
Alpha-D-Glucose	HMDB_SMPDB	Samples:	4	Pathways:	14	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Gluconeogenesis	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Fructose intolerance, hereditary	Glycolysis	Fructosuria	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease
Beta-D-Glucose 6-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	16	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease	Transaldolase deficiency	Fanconi-bickel syndrome	Warburg Effect	Glycolysis	Glucose-6-phosphate dehydrogenase deficiency
alpha-D-Glucose	HMDB_SMPDB	Samples:	4	Pathways:	14	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Gluconeogenesis	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Fructose intolerance, hereditary	Glycolysis	Fructosuria	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease
beta-D-Glucose	HMDB_SMPDB	Samples:	4	Pathways:	11	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycolysis	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease
beta-D-Glucose 6-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	16	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease	Transaldolase deficiency	Fanconi-bickel syndrome	Warburg Effect	Glycolysis	Glucose-6-phosphate dehydrogenase deficiency
Glucose 6-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	16	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease	Transaldolase deficiency	Fanconi-bickel syndrome	Warburg Effect	Glycolysis	Glucose-6-phosphate dehydrogenase deficiency
D-Glucose 6-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	16	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease	Transaldolase deficiency	Fanconi-bickel syndrome	Warburg Effect	Glycolysis	Glucose-6-phosphate dehydrogenase deficiency
Presqualene diphosphate	HMDB_SMPDB	Samples:	3	Pathways:	1	Steroid Biosynthesis
(R)-5-Diphosphomevalonate	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
(R)-5-Phosphomevalonate	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
(R)-Mevalonate	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
14-Demethyllanosterol	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
4,4-Dimethyl-5alpha-cholesta-8-en-3beta-ol	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
4alpha-Methylzymosterol	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
4alpha-Methylzymosterol-4-carboxylate	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
5alpha-Cholest-8-en-3beta-ol	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
5alpha-Cholesta-7,24-dien-3beta-ol	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
Dimethylallyl diphosphate	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
Formate	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
Geranyl diphosphate	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
Isopentenyl diphosphate	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
Lanosterol	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
trans,trans-Farnesyl diphosphate	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
Zymosterol	HMDB_SMPDB	Samples:	3	Pathways:	23	Cholesteryl ester storage disease	Steroid Biosynthesis	Hypercholesterolemia	Cerivastatin Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Zoledronate Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Hyper-IgD syndrome	Ibandronate Action Pathway	Lovastatin Action Pathway	Simvastatin Action Pathway	Desmosterolosis	Risedronate Action Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Pamidronate Action Pathway	Alendronate Action Pathway	Wolman disease	Pravastatin Action Pathway	CHILD Syndrome	Fluvastatin Action Pathway	Rosuvastatin Action Pathway	Atorvastatin Action Pathway	Mevalonic aciduria
Zinc	HMDB_SMPDB	Samples:	5	Pathways:	4	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Insulin Signalling	Fc Epsilon Receptor I Signaling in Mast Cells
D-myo-Inositol 1,4,5-trisphosphate	HMDB_SMPDB	Samples:	2	Pathways:	3	Phosphatidylinositol Phosphate Metabolism	Joubert syndrome	Fc Epsilon Receptor I Signaling in Mast Cells
L-Methionine	HMDB_SMPDB	Samples:	5	Pathways:	1	Spermidine and Spermine Biosynthesis
3-Phosphoglyceric acid	HMDB_SMPDB	Samples:	5	Pathways:	12	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Warburg Effect	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycolysis	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease
Glycerate 3-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	12	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Warburg Effect	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycolysis	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease
Tetrahydrofolate	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Fe2+	HMDB_SMPDB	Samples:	5	Pathways:	6	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	The oncogenic action of Fumarate	Pentose Phosphate Pathway	The oncogenic action of Succinate	Glucose-6-phosphate dehydrogenase deficiency
D-Mannose	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
L-Fucose	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
Sorbitol	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
D-Fructose 2,6-bisphosphate	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
Glyceraldehyde	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
Fructose 1,6-bisphosphate	HMDB_SMPDB	Samples:	5	Pathways:	19	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Fructosuria	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Fructose intolerance, hereditary	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Transaldolase deficiency	Fanconi-bickel syndrome	Warburg Effect	Glycolysis	Gluconeogenesis	Glucose-6-phosphate dehydrogenase deficiency
Fructose 1-phosphate	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
Mannose 6-phosphate	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
GDP-L-fucose	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
D-Glyceraldehyde 3-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	20	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Fructosuria	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Fructose intolerance, hereditary	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Transaldolase deficiency	Fanconi-bickel syndrome	Warburg Effect	Mitochondrial Electron Transport Chain	Glycolysis	Gluconeogenesis	Glucose-6-phosphate dehydrogenase deficiency
Guanosine diphosphate mannose	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
Fucose 1-phosphate	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
GDP-4-Dehydro-6-deoxy-D-mannose	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
Dihydroxyacetone phosphate	HMDB_SMPDB	Samples:	5	Pathways:	20	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Fructosuria	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Fructose intolerance, hereditary	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Transaldolase deficiency	Fanconi-bickel syndrome	Warburg Effect	Mitochondrial Electron Transport Chain	Glycolysis	Gluconeogenesis	Glucose-6-phosphate dehydrogenase deficiency
D-Mannose 1-phosphate	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
Beta-D-Fructose 2-phosphate	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
6-Deoxy-L-galactose	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
beta-D-Fructose 2,6-bisphosphate	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
beta-D-Fructose 2-phosphate	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
D-Fructose 1,6-bisphosphate	HMDB_SMPDB	Samples:	5	Pathways:	19	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Fructosuria	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Fructose intolerance, hereditary	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Transaldolase deficiency	Fanconi-bickel syndrome	Warburg Effect	Glycolysis	Gluconeogenesis	Glucose-6-phosphate dehydrogenase deficiency
D-Fructose 1-phosphate	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
D-Mannose 6-phosphate	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
D-Sorbitol	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
GDP-4-dehydro-6-deoxy-D-mannose	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
GDP-mannose	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
Glyceraldehyde 3-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	20	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Fructosuria	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Fructose intolerance, hereditary	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Transaldolase deficiency	Fanconi-bickel syndrome	Warburg Effect	Mitochondrial Electron Transport Chain	Glycolysis	Gluconeogenesis	Glucose-6-phosphate dehydrogenase deficiency
Glycerone phosphate	HMDB_SMPDB	Samples:	5	Pathways:	20	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Fructosuria	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Fructose intolerance, hereditary	Fructose and Mannose Degradation	Glycogenosis, Type VII. Tarui disease	Transaldolase deficiency	Fanconi-bickel syndrome	Warburg Effect	Mitochondrial Electron Transport Chain	Glycolysis	Gluconeogenesis	Glucose-6-phosphate dehydrogenase deficiency
L-Fucose 1-phosphate	HMDB_SMPDB	Samples:	3	Pathways:	3	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary
Histamine	HMDB_SMPDB	Samples:	2	Pathways:	2	Intracellular Signalling Through Histamine H2 Receptor and Histamine	Fc Epsilon Receptor I Signaling in Mast Cells
Histamium	HMDB_SMPDB	Samples:	2	Pathways:	2	Intracellular Signalling Through Histamine H2 Receptor and Histamine	Fc Epsilon Receptor I Signaling in Mast Cells
IMP	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
N6-(1,2-Dicarboxyethyl)-AMP	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
cis-Aconitic acid	HMDB_SMPDB	Samples:	5	Pathways:	13	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Congenital lactic acidosis	The oncogenic action of Fumarate	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E2)	Glutaminolysis and Cancer
Citric acid	HMDB_SMPDB	Samples:	5	Pathways:	14	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	Warburg Effect	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Congenital lactic acidosis	The oncogenic action of Fumarate	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E2)	Glutaminolysis and Cancer
L-Malic acid	HMDB_SMPDB	Samples:	5	Pathways:	14	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	Warburg Effect	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Congenital lactic acidosis	The oncogenic action of Fumarate	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E2)	Glutaminolysis and Cancer
Isocitric acid	HMDB_SMPDB	Samples:	5	Pathways:	14	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	Warburg Effect	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Congenital lactic acidosis	The oncogenic action of Fumarate	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E2)	Glutaminolysis and Cancer
D-2-Hydroxyglutaric acid	HMDB_SMPDB	Samples:	5	Pathways:	1	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 
Coenzyme Q10	HMDB_SMPDB	Samples:	5	Pathways:	15	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	Warburg Effect	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial Electron Transport Chain	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E2)	Glutaminolysis and Cancer
FADH	HMDB_SMPDB	Samples:	5	Pathways:	14	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	Warburg Effect	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Congenital lactic acidosis	The oncogenic action of Fumarate	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E2)	Glutaminolysis and Cancer
2-Hydroxyglutarate	HMDB_SMPDB	Samples:	5	Pathways:	5	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	The oncogenic action of Fumarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of Succinate
QH(2)	HMDB_SMPDB	Samples:	5	Pathways:	11	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	2-ketoglutarate dehydrogenase complex deficiency	Warburg Effect	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Congenital lactic acidosis	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E2)
Risedronate	HMDB_SMPDB	Samples:	3	Pathways:	1	Risedronate Pathway
L-Lysine	HMDB_SMPDB	Samples:	5	Pathways:	1	Glutaric Aciduria Type I
Oxoadipic acid	HMDB_SMPDB	Samples:	5	Pathways:	1	Glutaric Aciduria Type I
Saccharopine	HMDB_SMPDB	Samples:	5	Pathways:	1	Glutaric Aciduria Type I
Aminoadipic acid	HMDB_SMPDB	Samples:	5	Pathways:	1	Glutaric Aciduria Type I
L-Pipecolic acid	HMDB_SMPDB	Samples:	5	Pathways:	1	Glutaric Aciduria Type I
Allysine	HMDB_SMPDB	Samples:	5	Pathways:	1	Glutaric Aciduria Type I
(S)-2,3,4,5-Tetrahydropiperidine-2-carboxylate	HMDB_SMPDB	Samples:	5	Pathways:	1	Glutaric Aciduria Type I
Adenine	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Adenosine	HMDB_SMPDB	Samples:	5	Pathways:	5	Mercaptopurine Action Pathway	Azathioprine Action Pathway	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Thioguanine Action Pathway
Deoxyinosine	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Deoxyguanosine	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Deoxyadenosine	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Guanine	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Guanosine	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Hypoxanthine	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Inosine	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Phosphoribosyl pyrophosphate	HMDB_SMPDB	Samples:	5	Pathways:	4	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Glucose-6-phosphate dehydrogenase deficiency
Xanthine	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Xanthosine	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
dGDP	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
10-Formyltetrahydrofolate	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
5-Phosphoribosylamine	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
5'-Phosphoribosyl-N-formylglycinamide	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Deoxyribose 1-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	4	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Glucose-6-phosphate dehydrogenase deficiency
dGTP	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Ribose 1-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	4	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Glucose-6-phosphate dehydrogenase deficiency
dADP	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
D-Ribose 5-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	8	Transaldolase deficiency	Warburg Effect	Mercaptopurine Action Pathway	Thioguanine Action Pathway	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Azathioprine Action Pathway	Glucose-6-phosphate dehydrogenase deficiency
IDP	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
1-(5'-Phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
1-(5'-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
1-(5-Phospho-D-ribosyl)-5-amino-4-imidazolecarboxylate	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
2',3'-Cyclic GMP	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
2-(Formamido)-N1-(5'-phosphoribosyl)acetamidine	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
2-Deoxy-D-ribose 1-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	7	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Azathioprine Action Pathway	Glucose-6-phosphate dehydrogenase deficiency	Thioguanine Action Pathway	Mercaptopurine Action Pathway
5'-Phosphoribosylglycinamide	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
5-Amino-4-imidazolecarboxyamide	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
5-Phospho-alpha-D-ribose 1-diphosphate	HMDB_SMPDB	Samples:	5	Pathways:	7	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Azathioprine Action Pathway	Glucose-6-phosphate dehydrogenase deficiency	Thioguanine Action Pathway	Mercaptopurine Action Pathway
ADP-ribose	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
alpha-D-Ribose 1-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	7	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Azathioprine Action Pathway	Glucose-6-phosphate dehydrogenase deficiency	Thioguanine Action Pathway	Mercaptopurine Action Pathway
Aminoimidazole ribotide	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
dAMP	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
dATP	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
dGMP	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
GMP	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
ITP	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
P1,P4-Bis(5'-guanosyl) tetraphosphate	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Urate	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Xanthosine 5'-phosphate	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Gluconolactone	HMDB_SMPDB	Samples:	5	Pathways:	4	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Glucose-6-phosphate dehydrogenase deficiency
D-Ribose	HMDB_SMPDB	Samples:	5	Pathways:	4	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Glucose-6-phosphate dehydrogenase deficiency
D-Ribulose 5-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	5	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Glucose-6-phosphate dehydrogenase deficiency	Warburg Effect
Xylulose 5-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	5	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Glucose-6-phosphate dehydrogenase deficiency	Warburg Effect
Acetaldehyde	HMDB_SMPDB	Samples:	5	Pathways:	4	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Glucose-6-phosphate dehydrogenase deficiency
Deoxyribose 5-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	4	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Glucose-6-phosphate dehydrogenase deficiency
D-Sedoheptulose 7-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	5	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Glucose-6-phosphate dehydrogenase deficiency	Warburg Effect
6-Phosphogluconic acid	HMDB_SMPDB	Samples:	5	Pathways:	5	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Glucose-6-phosphate dehydrogenase deficiency	Warburg Effect
D-Erythrose 4-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	5	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Glucose-6-phosphate dehydrogenase deficiency	Warburg Effect
2-Deoxy-D-ribose 5-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	4	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Glucose-6-phosphate dehydrogenase deficiency
6-Phospho-D-gluconate	HMDB_SMPDB	Samples:	5	Pathways:	5	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Glucose-6-phosphate dehydrogenase deficiency	Warburg Effect
D-Glucono-1,5-lactone	HMDB_SMPDB	Samples:	5	Pathways:	4	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Glucose-6-phosphate dehydrogenase deficiency
D-Xylulose 5-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	5	Transaldolase deficiency	Ribose-5-phosphate isomerase deficiency	Pentose Phosphate Pathway	Glucose-6-phosphate dehydrogenase deficiency	Warburg Effect
Myoinositol	HMDB_SMPDB	Samples:	2	Pathways:	2	Phosphatidylinositol Phosphate Metabolism	Joubert syndrome
myo-Inositol	HMDB_SMPDB	Samples:	2	Pathways:	2	Phosphatidylinositol Phosphate Metabolism	Joubert syndrome
S-Adenosylmethioninamine	HMDB_SMPDB	Samples:	5	Pathways:	1	Spermidine and Spermine Biosynthesis
5'-Methylthioadenosine	HMDB_SMPDB	Samples:	5	Pathways:	1	Spermidine and Spermine Biosynthesis
Spermidine	HMDB_SMPDB	Samples:	5	Pathways:	1	Spermidine and Spermine Biosynthesis
Putrescine	HMDB_SMPDB	Samples:	5	Pathways:	1	Spermidine and Spermine Biosynthesis
Cortisol	HMDB_SMPDB	Samples:	2	Pathways:	1	Corticotropin Activation of Cortisol Production
Cytidine monophosphate	HMDB_SMPDB	Samples:	2	Pathways:	2	Phosphatidylinositol Phosphate Metabolism	Joubert syndrome
CMP	HMDB_SMPDB	Samples:	2	Pathways:	2	Phosphatidylinositol Phosphate Metabolism	Joubert syndrome
(S)-2-Hydroxyglutarate	HMDB_SMPDB	Samples:	5	Pathways:	1	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria
(S)-Malate	HMDB_SMPDB	Samples:	5	Pathways:	13	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Congenital lactic acidosis	The oncogenic action of Fumarate	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E2)	Glutaminolysis and Cancer
cis-Aconitate	HMDB_SMPDB	Samples:	5	Pathways:	12	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Congenital lactic acidosis	The oncogenic action of Fumarate	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E2)	Glutaminolysis and Cancer
Citrate	HMDB_SMPDB	Samples:	5	Pathways:	13	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Congenital lactic acidosis	The oncogenic action of Fumarate	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E2)	Glutaminolysis and Cancer
FADH2	HMDB_SMPDB	Samples:	5	Pathways:	13	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Congenital lactic acidosis	The oncogenic action of Fumarate	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E2)	Glutaminolysis and Cancer
Isocitrate	HMDB_SMPDB	Samples:	5	Pathways:	13	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Congenital lactic acidosis	The oncogenic action of Fumarate	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E2)	Glutaminolysis and Cancer
NH4+	HMDB_SMPDB	Samples:	5	Pathways:	2	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	The oncogenic action of 2-hydroxyglutarate
Ubiquinone-10	HMDB_SMPDB	Samples:	5	Pathways:	14	Pyruvate dehydrogenase deficiency (E3)	Mitochondrial complex II deficiency	Fumarase deficiency	The oncogenic action of Succinate	2-ketoglutarate dehydrogenase complex deficiency	Warburg Effect	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial Electron Transport Chain	The oncogenic action of 2-hydroxyglutarate	Citric Acid Cycle	Pyruvate dehydrogenase deficiency (E2)	Glutaminolysis and Cancer
Glycerol 3-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	1	Mitochondrial Electron Transport Chain
sn-Glycerol 3-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	1	Mitochondrial Electron Transport Chain
Ascorbic acid	HMDB_SMPDB	Samples:	5	Pathways:	2	The oncogenic action of Fumarate	The oncogenic action of Succinate
Copper	HMDB_SMPDB	Samples:	5	Pathways:	1	Degradation of Superoxides
Ascorbate	HMDB_SMPDB	Samples:	5	Pathways:	2	The oncogenic action of Fumarate	The oncogenic action of Succinate
4-Hydroxyproline	HMDB_SMPDB	Samples:	5	Pathways:	2	The oncogenic action of Fumarate	The oncogenic action of Succinate
Hydroxyproline	HMDB_SMPDB	Samples:	5	Pathways:	2	The oncogenic action of Fumarate	The oncogenic action of Succinate
Ubiquinol	HMDB_SMPDB	Samples:	5	Pathways:	3	The oncogenic action of Fumarate	The oncogenic action of Succinate	Glutaminolysis and Cancer
Stearic acid	HMDB_SMPDB	Samples:	2	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
Stearoyl-CoA	HMDB_SMPDB	Samples:	2	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
Octadecanoic acid	HMDB_SMPDB	Samples:	2	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
Adefovir Dipivoxil	HMDB_SMPDB	Samples:	3	Pathways:	1	Adefovir Dipivoxil Metabolism Pathway
L-Lactic acid	HMDB_SMPDB	Samples:	5	Pathways:	10	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Warburg Effect	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Gluconeogenesis	Glutaminolysis and Cancer
Malic acid	HMDB_SMPDB	Samples:	5	Pathways:	9	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of Fumarate	Gluconeogenesis
Glyceric acid 1,3-biphosphate	HMDB_SMPDB	Samples:	5	Pathways:	13	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Warburg Effect	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Mitochondrial Electron Transport Chain	Glycolysis	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease
2,3-Diphosphoglyceric acid	HMDB_SMPDB	Samples:	4	Pathways:	11	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycolysis	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease
2-Phospho-D-glyceric acid	HMDB_SMPDB	Samples:	5	Pathways:	12	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Warburg Effect	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycolysis	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease
(S)-Lactate	HMDB_SMPDB	Samples:	5	Pathways:	10	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Warburg Effect	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Gluconeogenesis	Glutaminolysis and Cancer
2,3-Bisphospho-D-glycerate	HMDB_SMPDB	Samples:	4	Pathways:	11	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycolysis	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease
2-Phospho-D-glycerate	HMDB_SMPDB	Samples:	5	Pathways:	12	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Warburg Effect	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycolysis	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease
3-Phospho-D-glyceroyl phosphate	HMDB_SMPDB	Samples:	5	Pathways:	13	Triosephosphate isomerase	Fanconi-bickel syndrome	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IC	Glycogenosis, Type IA. Von gierke disease	Warburg Effect	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Mitochondrial Electron Transport Chain	Glycolysis	Gluconeogenesis	Glycogenosis, Type VII. Tarui disease
Malate	HMDB_SMPDB	Samples:	5	Pathways:	9	Triosephosphate isomerase	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type IC	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycogenosis, Type IA. Von gierke disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	The oncogenic action of Fumarate	Gluconeogenesis
Leukotriene D4	HMDB_SMPDB	Samples:	2	Pathways:	1	Fc Epsilon Receptor I Signaling in Mast Cells
Methylmalonyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	1	Valine, Leucine and Isoleucine Degradation
6-Methylmercaptopurine	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
6-Thiourate	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Azathioprine	HMDB_SMPDB	Samples:	1	Pathways:	1	Azathioprine Action Pathway
1-Methyl-4-nitroimidazole	HMDB_SMPDB	Samples:	1	Pathways:	1	Azathioprine Action Pathway
Caproic acid	HMDB_SMPDB	Samples:	2	Pathways:	1	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids
Hexanoic acid	HMDB_SMPDB	Samples:	2	Pathways:	1	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids
Caprylic acid	HMDB_SMPDB	Samples:	2	Pathways:	1	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids
(2E)-Dodecenoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	3	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)
Heparin	HMDB_SMPDB	Samples:	2	Pathways:	1	Fc Epsilon Receptor I Signaling in Mast Cells
Ubiquinol 8	HMDB_SMPDB	Samples:	5	Pathways:	1	Mitochondrial Electron Transport Chain
Tenofovir	HMDB_SMPDB	Samples:	3	Pathways:	1	Tenofovir Metabolism Pathway
Leukotriene E4	HMDB_SMPDB	Samples:	2	Pathways:	1	Fc Epsilon Receptor I Signaling in Mast Cells
Phosphatidylinositol-3,4,5-trisphosphate	HMDB_SMPDB	Samples:	2	Pathways:	1	Fc Epsilon Receptor I Signaling in Mast Cells
Mono- and diglycerides	HMDB_SMPDB	Samples:	2	Pathways:	1	Fc Epsilon Receptor I Signaling in Mast Cells
CDP-DG(16:0/18:1(9Z))	HMDB_SMPDB	Samples:	2	Pathways:	2	Phosphatidylinositol Phosphate Metabolism	Joubert syndrome
DG(16:0/18:1(9Z)/0:0)	HMDB_SMPDB	Samples:	2	Pathways:	2	Phosphatidylinositol Phosphate Metabolism	Joubert syndrome
PI(16:0/18:1(9Z))	HMDB_SMPDB	Samples:	2	Pathways:	2	Phosphatidylinositol Phosphate Metabolism	Joubert syndrome
PIP[3'](16:0/18:1(9Z))	HMDB_SMPDB	Samples:	2	Pathways:	1	Phosphatidylinositol Phosphate Metabolism
PIP(18:1(9Z)/16:0)	HMDB_SMPDB	Samples:	2	Pathways:	2	Phosphatidylinositol Phosphate Metabolism	Joubert syndrome
PIP2(16:0/18:1(9Z))	HMDB_SMPDB	Samples:	2	Pathways:	2	Phosphatidylinositol Phosphate Metabolism	Joubert syndrome
PIP3(16:0/18:1(9Z))	HMDB_SMPDB	Samples:	2	Pathways:	2	Phosphatidylinositol Phosphate Metabolism	Joubert syndrome
1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol	HMDB_SMPDB	Samples:	2	Pathways:	2	Phosphatidylinositol Phosphate Metabolism	Joubert syndrome
Prednisolone	HMDB_SMPDB	Samples:	3	Pathways:	2	Prednisolone Metabolism Pathway	Prednisolone Pathway
Superoxide	HMDB_SMPDB	Samples:	5	Pathways:	1	Degradation of Superoxides
O2.-	HMDB_SMPDB	Samples:	5	Pathways:	1	Degradation of Superoxides
Ibandronate	HMDB_SMPDB	Samples:	3	Pathways:	1	Ibandronate Pathway
6-Hydroxyfluvastatin	HMDB_SMPDB	Samples:	3	Pathways:	1	Fluvastatin Pathway
Fluvastatin	HMDB_SMPDB	Samples:	3	Pathways:	2	Fluvastatin Action Pathway	Fluvastatin Pathway
PIP2(16:0/16:0)	HMDB_SMPDB	Samples:	5	Pathways:	3	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Insulin Signalling
PIP3(16:0/16:0)	HMDB_SMPDB	Samples:	5	Pathways:	3	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Insulin Signalling
Zoledronate	HMDB_SMPDB	Samples:	3	Pathways:	1	Zoledronate Pathway
5-Amino-2-oxopentanoic acid	HMDB_SMPDB	Samples:	5	Pathways:	1	Fatty Acid Elongation In Mitochondria
2-trans-Dodecenoyl-CoA	HMDB_SMPDB	Samples:	5	Pathways:	2	Fatty Acid Elongation In Mitochondria	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)
Alendronic acid	HMDB_SMPDB	Samples:	3	Pathways:	2	Alendronate pathway	Alendronate Action Pathway
Lovastatin	HMDB_SMPDB	Samples:	3	Pathways:	2	Lovastatin Action Pathway	Lovastatin Pathway
Stearoylcarnitine	HMDB_SMPDB	Samples:	2	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
3-Oxooctadecanoyl-CoA	HMDB_SMPDB	Samples:	2	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
trans-Octadec-2-enoyl-CoA	HMDB_SMPDB	Samples:	2	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
(S)-Hydroxyoctadecanoyl-CoA	HMDB_SMPDB	Samples:	2	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
(2E)-Octadecenoyl-CoA	HMDB_SMPDB	Samples:	2	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
3-Oxostearoyl-CoA	HMDB_SMPDB	Samples:	2	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
L-Octanoylcarnitine	HMDB_SMPDB	Samples:	2	Pathways:	1	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids
Atorvastatin	HMDB_SMPDB	Samples:	3	Pathways:	2	Atorvastatin Pathway	Atorvastatin Action Pathway
Doxorubicin	HMDB_SMPDB	Samples:	1	Pathways:	1	Doxorubicin Metabolism Pathway
Simvastatin	HMDB_SMPDB	Samples:	3	Pathways:	1	Simvastatin Action Pathway
6-Phosphonoglucono-D-lactone	HMDB_SMPDB	Samples:	5	Pathways:	1	Warburg Effect
D-Glucono-1,5-lactone 6-phosphate	HMDB_SMPDB	Samples:	5	Pathways:	1	Warburg Effect
Pravastatin	HMDB_SMPDB	Samples:	3	Pathways:	2	Pravastatin Pathway	Pravastatin Action Pathway
Rosuvastatin	HMDB_SMPDB	Samples:	3	Pathways:	1	Rosuvastatin Pathway
Pamidronate	HMDB_SMPDB	Samples:	3	Pathways:	2	Pamidronate Action Pathway	Pamidronate Pathway
Spermine	HMDB_SMPDB	Samples:	5	Pathways:	1	Spermidine and Spermine Biosynthesis
6-Thioguanosine monophosphate	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
6-Thioinosine-5'-monophosphate	HMDB_SMPDB	Samples:	1	Pathways:	3	Thioguanine Action Pathway	Azathioprine Action Pathway	Mercaptopurine Action Pathway
Risedronic acid	HMDB_SMPDB	Samples:	3	Pathways:	1	Risedronate Action Pathway
